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INTRODUCTION 
 
 
1. BACKGROUND: 
Mood disorders encompass a large group of psychiatric disorders 
in which pathological moods and related vegetative and psychomotor 
disturbances dominate the clinical picture. Mood disorders are best 
considered as syndromes (rather than discrete diseases) consisting of a 
cluster of signs and symptoms, sustained over a period of weeks to 
months, that represent a marked departure from a person’s habitual 
functioning and tend to recur, often in periodic or cyclical fashion1. 
Bipolar disorder is a complex clinical spectrum, that may present 
with a variety of shifting signs and symptoms ranging from sub threshold 
mood symptoms to full blown psychotic symptoms2It can result in 
distress, disability, suicide and death and burdens relatives, caregivers 
and society. It is also a cause of stigma due to the cognitive impairment it 
produces3 
Mania, the most characteristic phase of the bipolar disorder4, is 
characterized by elated or irritable mood, increased psychomotor activity 
excessive speech, grandiose ideas, excessive spending and unwise 
investments . Bipolar Type 1 disorder occurs in1.6% of general 
population5and up to 8.2% of patients attending Psychiatric OPD6.  
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Mapping the course of bipolar disorder systematically from onset is 
a critical research challenge7. Studies have shown changes in the course 
of illness with repeated episodes and change in responsiveness to 
subsequent therapeutic interventions7in bipolar disorder. 
Studies suggest that the response to therapy in BPAD is a disease 
dependent factor8. Prediction of illness course early in bipolar disorder is 
required to guide treatment planning6. Identification of factors 
contributing to differential outcomes and subtyping the disorder has led to 
advances in the treatment of bipolar disorder. It helps psychiatrists in 
initiating treatment strategies most likely to be effective and to predict 
response to therapy9.  
In recent years, new treatment options of bipolar disorders, 
particularly for manic episodes have been developed. Newer medications 
including novel atypical antipsychotics and second and third generation 
anticonvulsants are being used in treatment of acute bipolar mania8 
In this study, we try to find the characteristics, course and outcome 
of manic episodes 
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AIMS AND OBJECTIVES 
AIMS:  
To study the characteristics of people suffering from manic 
episode, the course of the illness in the current available treatment 
scenario and analyze the factors associated with differential outcomes.  
OBJECTIVES: 
  To study the baseline socio demographic and illness characteristics 
of the patients suffering from mania. 
 To study the time required for attaining remission of symptoms 
with treatment in inpatient and outpatient setting. 
 To calculate SOFAS score as a indicator of functional outcome 
 To classify outcome as good or bad based on SOFAS score and 
time to remission (Short or long) and analyze the predictive factors 
associated with good or bad outcomes. 
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REVIEW OF LITERATURE 
Bipolar disorder, described as early as 1st century by Aretoeus10 of 
Cappadocia, attained a full form after being reformulated by the French 
psychiatrists in the 19th century. The first monograph, using the term 
mania in its current meaning was published by Emmanuel mendel11 in 
1881. The growth culminated when the term ‘manic- depressive’ insanity 
was coined by Emil kraeplin12 in 1921. 
Studies show that the initial symptoms of mania are increased self 
esteem followed by insomnia and irritability. The patient’s speech is fast, 
is easily distractible, may have clang associations and loose. The behavior 
is typically dramatic, expansive, and jesting. Current research indicates 
that social disinhibition and pathological overfamiliarity with strangers 
represent cardinal features of mania.  
The mood in mania is euphoric or elated, but could also be labile, 
irritable or hostile. It is characterized by increased energy and activity 
which is the hallmark feature. Eutonia, accelerated thinking process, 
sharp and colourful perception are found. Manic thinking isvery much 
expansive, positive, optimistic assosciated with poor judgement and 
sexual indiscretion and disinhibited behaviour. There can be assosciated, 
delusions (grandiose and erotomanic). Mania is categorizedinto three 
types., i.e acute, delusional and delirious by Kraeplin13. A spectrum of 
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evolution of mania in 5 stages is proposed by klerman14, ie normal, 
neurotic, hypomanic, manic and delirious 
Psychosis in the setting of mania and mixed manic episodes is 
typically mood congruent. Hypomania is sometimes regarded as positive 
health state. The recurrences of manic symptoms can produce impairment 
in social, occupational domains and can lead to loss of reputation. 
Misdiagnosis occurs with most severe forms specially those presenting 
with psychotic symptoms which mimic schizophrenia, or milder forms 
which may be mistaken for personality disorders. 
Mania in ICD 11 is defined as an extreme mood state, lasting 
atleast 1 week unless shortened by treatment intervention, characterized 
by Euphoria, irritability or expansiveness, and by increased activity or a 
subjective experience of increased energy accompanied by other 
characteristic symptoms such as rapid or pressured speech, flight of ideas, 
increased self-esteem or grandiosity,decreased need for sleep, 
distractibility, impulsive or reckless behaviour and rapid changes among 
different mood states ( mood lability). Mania is given a place in bipolar 1 
disorder in ICD-11.  
DSM 5 also doesnot classify unipolar mania as a separate entrity, 
but merges it to bipolar I classification. Occurrence of one single episode 
of mania is sufficient for diagnosis of bipolar I disorder. DSM5 defines 
Criteria A-D constitute a manic episode 
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A. A distinct period of abnormally and persistently elevated, 
expansive, or irritable mood and abnormally and persistently increased 
activity or energy, lasting at least 1 week and present most of the day, 
nearly every day (or any duration if hospitalization is necessary).  
B. During the period of mood disturbance and increased energy 
and activity, three (or more) of the following symptoms (four if the mood 
is only irritable) are present to a significant degree and represent a 
noticeable change from usual behavior: 
1. Inflated self-esteem or grandiosity 
2. Decreased need for sleep (eg, feels rested after only 3 hours of 
sleep) 
3. More talkative than usual or pressure to keep talking 
4. Flight of ideas or subjective experience that thoughts are racing 
5. Distractibility (ie, attention too easily drawn to unimportant or 
irrelevant external stimuli), as reported or observed 
6. Increase in goal-directed activity (either socially, at work or 
school, or sexually) or psychomotor agitation 
7. Excessive involvement in activities that have a high potential for 
painful consequences (eg, engaging in unrestrained buying sprees, sexual 
indiscretions, or foolish business investments) 
C. The mood disturbance is sufficiently severe to cause marked 
impairment in social or occupational functioning or to necessitate 
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hospitalization to prevent harm to self or others, or there are psychotic 
features. 
D. The episode is not attributable to the physiological effects of a 
substance (eg, a drug of abuse, a medication, other treatment) or to 
another medical condition.  
A full manic episode that emerges during antidepressant treatment 
(eg, medication, electroconvulsive therapy) but persists at a fully 
syndromic level beyond the physiological effect of that treatment is 
sufficient evidence for a manic episode. 
A mixed episode is characterized by either a mixture or very rapid 
alteration between prominent manic and depressive symptoms on most of 
the days during a period of at least 2 weeks. 
Debate over establishing mania as a separate disorder, apart from 
the bipolar illness, has been there over centuries. Carl Wernicke15 (1848-
1905) described mania as a state of hyper function of nerve transmission 
and activity, as a different disorder from its counterpart, melancholia, 
defined by nerve hypo function or a function, also these two frequently co 
existed. Kleist16dichotomized unipolar from bipolar conditions. Mania 
was distinguished from bipolar disorder in 1978 by Angst et al. Two large 
epidemiological studies show prevalence of unipolar mania 1.7% and 
1.8% respectively in adolescents (12-17) and adults (21-34 yrs) ( 
BeesdoBaum et al 200917). Three or more manic episode in patients who 
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have not shown any depressive episodes show diagnostic stability. But 
for pure mania the conversion rates to bipolar was 2.7 year, which is 
much more than that for major depressive disorder. Comparatively 
unipolar mania has earlier age at onset, higher rates of psychotic 
symptoms, less rapid cycling, fewer suicide attempts, higher rates of 
hyperthymic temperament, complete absence of depressive temperament, 
less anxiety and long term functional adjustment (Pacheho Palha et al 
2009)18. There are also evidences which indicate, the condition responds 
to valproate better than lithium. CCDM 2 has a special coding for 
unipolar mania. The heritability of unipolar mania is higher (0.83) 
The concept of bipolar spectrum disorder proposed by Akiskal19, 
backed by the original approach to the bipolar spectrum concept , put 
forth by Koukopoulos20, is the primacy of mania theory, the notion that 
depression cannot happen without mania maps back to Kraepelin's 
original, much broader notion of manic-depressive illness. Koukopoulos 
said, mania and depression always go together; the Leonhardian/DSM-III 
project of dividing it is thus misguided. Koukopoulos defines mania 
broadly, as any form of excitation also includes psychomotor agitation, 
marked anxiety, and mood temperaments like hyperthymia or 
cyclothymia. Koukopoulos' hypothesis is that there will be the co-
occurrence or prior occurrence of mania in all depressive episodes. Thus, 
often, depressive episodes follow manic episodes; or they occur after 
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years of hyperthymic or cyclothymic temperament, or they represent 
mixed depression as defined above. Pure depression, in the absence of 
any of the manic-like features, is very rare in his view. 
Manic episodes can be naturally classified as Classic or 
Predominantly euphoric type, dysphoric or depressedor mixed type  
 
A review of the natural course of bipolar disorders: 
Studies on the characteristics and course of the bipolar illness has 
happened since the last half of the 19th century. The studies done in the 
predrug era help us understand the natural course of the disorder. 
Esquirol21 in 1845 in his book ‘Mental maladies- A treatise on insanities’ 
describes his prospective study where patients admitted with the 
diagnosis of manic depressive disorder, over a period of four years were 
followed up till their discharge from the hospital. Many such drug naïve 
studies were done later. Baeur M22 (2005) considers reconceptualizing 
bipolar illnesses as highly recurrent, malignant disorders that occur far 
more frequently than previously thought. ( Epilepsia) 
Prevalence: 
The prevalence of bipolar 1 disorder (12 month and lifetime) 2.0 
and 3.3% respectively (BF Grant 2005) ( JCP). The prevalence was low 
in Asians and Hispanics when compared to native Americans. 
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Characteristics: 
Age of onset: Compared to depression, mania has a relatively early 
age at onset. The age of onset was 26.74±11.03 years (Ram et al, 2001)23. 
Age at onset of first lifetime affective episode was 22.9 years with a SD 
of 10 years (Lewis L Judd, 2002)24. BPI more prevalent among younger 
adults (BF grant 2005)25 
The age of onset was 27.7+ or – 9.1 years with a range of 14- 49 
years in a study done in naturalistic setting in rural India (Mohit P Chopra 
2006)26. The median age of onset was 24.67 years (Khanna et al.,1992)27 
Gender: Gender has a role in both presentation and course of 
bipolar disorders. Bipolar I disorder affects men and women with equal 
frequencies. However, Bipolar II appears to be more common in women. 
About 80–90% of malignant type of rapid-cycling bipolar disorder occur 
in women (Baeur M 2005)28. Women also experience mixed episodes and 
manic switches during antidepressant treatment more commonly. 
Comorbid medical and psychiatric illness are more common in women 
than in men. Treatment options vary among men and women due to 
menstrual cycle and reproductive concerns. Individualized risk–benefit 
assessments are to be done to avoid or limit exposure of the fetus or 
infant to potential adverse effects of medication.  
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Men were more likely to have unipolar mania and earlier onset and 
longer duration of manic episodes, while women were more likely to 
have mixed and major depressive episodes (Grant BF 2005)25 
Seasonality: Seasonality exists in mania. Mania is thought to be a 
disease of spring and summer25a. Studies find that the seasonality in 
mania occurs mainly in males, above the age of 25 years25b. Manic illness 
with seasonality is found to be cycling rapidly25c. In sharp contrast to the 
studies from western literature, a study done in southern part of India, 
finds a increasing admission for manic episodes in the months of October 
and November, during rains25b. 
Family History: The IOWA studies describe a prevalence of 
5.35% incidence of bipolar disorder among relatives of patients with 
bipolar disorder by analysis of clinical records and cross-interviewing of 
relatives and by diagnostic interviewing  
Marital status: The presence of mania, hypomania, or major 
depression is a strong predictor for future separation or divorce. This 
could result in serious distress for the patients and for their spouses and 
may generate negative life events for their children and also could disrupt 
the necessary support system needed for the identification, hospitalization 
and care taking including consenting for procedures and medications, 
procuring medications regularly for outpatient care and maintaining 
compliance) of the patients during the periods of absence of insight. 
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These early negative life events (e.g., parental loss before adolescence) 
are well-known predisposing factors for adult mood disorders, 
particularly in the case of family loading (case of subjects with positive 
family history of mood disorders). 
Socioeconomic status: There is no clear-cut association between 
SES and mood disorders. But mood disorders may result in 
unemployment, low income and divorcein addition to the hospital costs 
involved can result in regression in socioeconomic status. This in turn 
could adversely affect the outcome of the illness. 
Substance use: Bipolar I disorder was found to be significantly 
related to substance use (but not alcohol), anxiety disorder and other 
personality disorders (Grant BF 2005)25. The co-occurrence of both 
manic symptoms and cocaine use predict sexual risk behavior in patients 
with co-occurring BD and SUD. Cocaine use predicted changes in sex 
risk score, with increases in cocaine use correlating with increases in 
sexual risk behavior during that follow-up period (estimate of slope = 
0.04, P<0.05). Specifically, for every 7-day increase in cocaine use, there 
was a 0.28-point increase in RAB score (Christina s Maede et al 2011)29. 
Other factors: traits:  
Trait-like impulsivity was substantially higher in subjects with 
bipolar disorder than in nonbipolar comparison subjects, regardless of 
symptoms. Within subjects with bipolar disorder, high trait impulsivity 
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was associated with a more severe course of illness ( Swaan AC)30. 
Akiskal (1996)31 has suggested that the behavior of the hyperthymic 
temperament may bring about situations that trigger manic episodes. High 
Conscientiousness, particularly the Achievement Striving facet, predicted 
increases in manic symptoms across time. Higher Novelty-Seeking scores 
(particularly the subscales of Impulsiveness and Disorderliness), as 
measured using the Tridimensional Personality Questionnaire, predicted a 
lack of functional recovery in the 6 months following a first episode of 
mania for 27 patients (Strakowski et al., 1993)32. Depue and others have 
hypothesized that mania is the outcome of dysregulation in the behavioral 
facilitation or behavioral activation system (BAS; Depue et al., 1994)33. 
BAS appears centrally tied to personality traits of positive affect, 
extraversion, and achievement striving, as well as variability within these 
traits (Depue and Collins, 1999)34. High activity within this system has 
been seen as the underlying basis for mania. Bipolar patients present 
higher levels of novelty seeking, harm avoidance and self-transcendence 
and lower levels of self-directedness and cooperativeness than healthy 
individuals. Bipolar patients with comorbid alcoholism had lower levels 
of persistence than those bipolar patients who never had any comorbidity 
(Nery FG 2008)35. Sparding36 et al (2017) the patients scored ≥1 SD 
above the population mean on the global measures of Neuroticism, 
Aggressiveness and Disinhibition; scores this high are usually evident 
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clinically. But, the personality profile does not seem to have prognostic 
value over a 2-year period. 
Childhood history: History of childhood psychopathology and 
childhood internalizing problems were associated with, longer time to 
remission and shorter times to relapse respectively (Bromet EJ 2005)37 
Course: About 60% of patients changed polarity once per year or 
less, while 19.2% changed polarity an average of more than 5 times per 
year, 8.2% changed polarity more than 10 times per year, and 4.1% 
changed polarity more than 20 times per year. ( Lewis L Judd 2002)38 
Patients without rapid cycling had a mean of 4.4 and a median of 3 
major mood episodes , resulting in a mean of 0.22 episodes/year (Mohit P 
Chopra2006)26 .Youths with bipolar I and bipolar disorder not otherwise 
specified spent significantly more follow-up time with subsyndromal  
 ( mania or mixed symptoms) than with syndromal symptoms over a four 
year follow-up period (60% symptomatic and 40% asymptomatic)  
 (Birmaher et al 2009)39 
Time taken for remission:  
Esquirol1845 describes mania as a chronic disorder. Henry M 
Swift (1907) reported that the recovery in between attacks is good., but 
the recurrence rate is high. He also added that both in mania and 
depression the duration of the second episode was longer than the first. 
Kraeplin in 1921 said that the attacks lasted 6-8 months initially and later 
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they tend to last longer. Disease appears more frequently later in the 
course of the illness (Kraeplin 1921, Lange 1928). Gunnar Landquist 
described a more chronic course of the illness, when the onset is over 50 
years.Werthiem (1929) described an average duration of 34.5 weeks in a 
study done on 2000 patients. 15% of the patients had a duration of 2 years 
or more. 
In a prospective four year study done in 2005 in a multifacility 
cohort, where patients were followed after their first admission for severe 
bipolar disorder, 42.3 % remitted in 3 months, 63.4% in 6 months and 
74.8% in a year. Of the patients unremitted at the end of one year only a 
further 8.9 5 achieved remission by the end of 4 years. The median time 
to remission in manic episode was 58.0 days ( 95% CI 54.9- 84.2 days) ( 
Leelahanaj et al 2013)40. A study done in Turkey the time taken to 
remission is 80.9 +or _ 73.8 9 Mean+ SD. Median duration was 50 days 
(Karan Kora et al 2008) 
The mean latency of 13.7 weeks (SD=21.8; median=5.6), and a 
survival computed time to 50% of subjects recovered of 5.4 weeks is 
observed in patients suffering first episode manic or mixed episodes. 
Survival computed proportions of subjects recovering by 3, 6, 12, and 24 
months, respectively, were 76.5%, 85.5%, 91.6%, and 97.6%. Nearly all 
subjects (97.6%, N=162) achieved syndromal recovery from their initial 
manic/mixed episode by 2 year ( Tohen et al 2003)41 
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Indian study done by Kumar R , Ram D42 2001 shows the mean 
duration of current episode to be 76.35 ± 51.36 days.An Indian study 
done by Santhosh Ramdurg et al (2017)43, identified the time taken for 
symptom remission in Mania as 109.3 ± 124.9 days, with a median of 90 
days and a range of 7- 730 days. Duration in weeks of a Manic episode 
was 13 ± 15.4  (Mean + SD) with a range of 2–91 weeks in a partially 
treated rural cohort studied in a naturalistic setting ( Mohit P Chopra 
2006)26. Kaplan-Meier estimates of the cumulative probabilities of 
recovering syndromally, symptomatically, and functionally during the 
first 12 months following initial hospitalization in a manic episode in 
adolescents were 0.86, 0.43, 0.41 (Debello et al 2007)44 respectively. 
Boys were more than twice as likely as girls to experience symptomatic 
recovery. The mean time to recovery was 44 ± 44 days in first episode 
mania adolescents and recovery from index episode was 100% (Rajiv 
jairam et al 2004)45 
Factors associated with shorter duration for remission: 
Ram K 200146 says the shorter the evolutionary period of 
symptoms, the shorter the time taken for remission. Shorter duration of 
hospitalization, female sex and lesser initial score on intake predicted 
earlier syndromic recovery in patients with first episode mania  
 (Tohenet al 2003)41. psychosis predicted more weeks ill with mania or 
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hypomania (F-1.80= 12.2). Pubertal status and sex were not predictive. 
(Geller et al 2004)47 
Factors associated with longer duration for remission: A 
younger age of onset, history of childhood psychopathology, and higher 
Brief Psychiatric Rating Scale (BPRS) anxiety/depression scores were 
significantly associated with longer time to remission. ( Bromet EJ 
2005)37. In adolescents, Individual predictors of poor syndromic recovery 
included co-occurring attention deficit hyperactivity disorder (ADHD), 
anxiety disorders, and disruptive behavior disorders as well as non 
adherence to psychotropic medication and lower socioeconomic levels 
(Debello et al 2007) 
Outcome: 
Esquirol (1845) said that the outcome is usually a dementia. Henry 
M Swift (1907) reported that the recovery in between attacks is good. He 
also said that the prognosis for depressive episodes are better than those 
for excitement. 
645 % had poor functioning at 6-12 months following manic 
remission as indicated by FAST scores greater than 11. (MS Wesley 
2018). The functioning was not influenced by occupational status, marital 
status or current living arrangements ( MS Wesley 2018)48 
Euthymic patients with bipolar disorder demonstrate cognitive 
impairments in attention/ processing speeds, episodic memory and 
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executive functioning. The effect size is medium to large which is 
suggestive of a neuropsychological impairment (LN Yatham, 2007)49 
(APS). Modest impairment in executive functioning, memory and 
attention in euthymic patients recovered from hypomania was reported  
(Gin S Malhi et al 2007)50 ( BD). Bipolar patients in remission presented 
significant impairment compared to healthy participants in all the basic 
cognitive functions tested with the exception of verbal memory. 
Moreover, patients had significant poorer performance than healthy 
controls in overall psy and cognitive ToM but not in affective ToM as 
measured by Faux Pas. In a study done on patients suffering from first 
episode mania, only 39.5% and 43.1% had achieved functional recovery 
according to residential and occupational status, at 6 and 24 months 
respectively. Another 13.3% had achieved and then lost functional 
recovery within 2 years of intake (Tohen et al, 2003) 
Factors associated with good outcome: Female sex, higher self 
esteem, healthy coping strategies, religion, positive reframing, planning, 
acceptance were associated with better outcome in FAST scores, 
Occupational functioning and leisure domains in FAST were negatively 
correlated with social support from family and friends. Longer duration 
from the last relapse, medication adherence was associated with good 
functioning (MS Wesley 2018). Shorter duration of hospitalization, 
greater age at first episode, married, lesser depression rating score at 
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study entry, female sex, absence of mood incongruent psychotic 
symptoms was associated with earlier functional recovery at 6 months 
follow-up. At 2 years follow-up sex difference and presence of psychotic 
symptoms lost the predictive value (Tohen et al 2003) 
Factors associated with bad outcome: Prolonged hospital stay, 
high stress levels, HDRS and YMRS score were associated with poor 
functioning. Behavior disengagement, self-blame increasing learned 
helplessness and substance abuse also were associated with high FAST 
scores. The earlier age at onset, previous psychotic episodes, 
comorbidities, and sub syndromal symptoms might also contribute to 
impaired functioning. The role of stress is due to the fact that chronic 
mood instability produces physiological stress with neurotoxic effects 
leading to cognitive decline and neurological damage. Residual 
symptoms and cognitive dysfunctions, especially deficits in social 
cognition (ToM) negatively affect psychosocial functioning of remitted 
patients with bipolar disorder. (Konstantakopoulos G, 2016)51 
Relapse: 1/3rd of the patients went in to depression immediately 
after a manic episode., whereas the viceversa does not occur (Thomas AC 
Rinnie 1913-1916). In a four year prospective study following first severe 
episode requiring hospitalization, 24.3 % relapsed within 6 months of 
remission, and 35.9% within a year,61.4 % relapsed by the end of the 
study period ( Bromet EJ,2005)37. Following a first manic episode, more 
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than one half of patients experience a mood event within one year. The 
mean time to mood event was 7.9 months ( Yatham LN, 2009)52 
Childhood internalizing-type problems, higher BPRS anxiety/depression 
and Hamilton depression scores, and an admission episode not involving 
mania, but not patterns of medication use, were associated with shorter 
time to relapse. In a four-year follow-up study, 1.1 syndromic recurrences 
were found in adolescent bipolar I patients of which 14.8% were after 
manic episodes. The type of relapse following manic episode was manic/ 
Hypomanic in 59% and depressive relapses (Birmaher et al 2009)7 .  
59.7 % were relapse free at 2 years, 19.3% switched into 
depression without recovery, 5.8 percent experienced relapse and 34.4% 
experienced recurrence at 2 year follow up following first episode mania. 
The average time taken for relapse was 26.3 weeks and for recurrence is 
32.3 weeks 
Risks of new episodes of mania and depression were equal in 
incidence, but latency to new depression was shorter than to new mania 
(17.7 versus 31.6 weeks) % relapsed after 18 ± 16.4 months and 74 % of 
relapses occurred while on treatment in first episode adolescent mania 
patients ( Rajiv Jairam et al 2004)45. 
Results from meta‐analyses showed a 1‐year rate of recurrence of 
35% in adults, and in adolescents/children, a 1‐year rate of recurrence of 
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48% , a 2‐year rate of 46% and a 4‐5‐year rate of recurrence of 65% ( LV 
Kessing et al 2017)53 
Factors associated with relapse and recurrence: In adolescents, 
Co-occurring alcohol use disorders, treatment with antidepressants, and 
the absence of psychotherapeutic intervention predicted syndromic 
recurrence (Debello et al 2007)54. 64 Low maternal warmth predicted 
faster relapse after recovery from mania (Geller et al, 2004). 
Treatment of bipolar mania: 
The latest NICE guidelines (CG 185,2014) recommends that if a 
person develops mania or hypomania and is not taking an antipsychotic 
or mood stabilizer, haloperidol, olanzapine, quetiapine, or risperidone, 
has to be started, taking into account any advance statements, the 
person’s preference, and clinical context (including physical comorbidity, 
previous response to treatment, and side effects). If the person is already 
taking lithium, check plasma lithium levels to optimize treatment and 
consider adding haloperidol, olanzapine, quetiapine, or risperidone. 
In the long-term management of bipolar disorder, psychoeducation 
of patient and family, psychotherapy for Bipolar disorder, long term 
maintenance with lithium (or antipsychotic if patient prefers) is 
recommended. If response is inadequate or adverse effects develop, 
Sodium Valproate or olanzapine may be considered. If quitiapin has been 
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effective previously, it can also be tried. Aripiprazole for 12 weeks 
duration is recommended in children as the first line drug. 
The IPS guidelines recommend first line agent for management of 
mania may involve use of lithium or valproate, olanzapine, haloperidol, 
quetiapine, aripiprazole, risperidone, paliperidone or ziprasidone as 
monotherapy. Typical antipsychotics like haloperidol, trifluoperazine and 
chlorpromazine can also be used. The combination of lithium or valproate 
with an antipsychotic may be more effective than any of these agents 
when used alone. Among these agents, lithium is thought to have slower 
onset of action. If the mania is less severe, monotherapy be considered. If 
mania is severe and associated with significant disruption than 
combination therapy can be used. Use of adjunctive benzodiazepines for 
short duration may be required. Patients who refuse medications and are 
unmanageable may be given depot antipsychotics like risperidone, 
paliperidone, olanzapine or a depot of typical antipsychotic medication. If 
the first-line agent used fails at the adequate dose level, (lack of 
significant clinical benefit after 2 weeks of use), another first line agent 
can be added to the ongoing treatment. Alternative strategies may include 
changing lithium to valproate or vice versa, changing to carbamazepine, 
adding antipsychotic medication if not used earlier, changing the 
antipsychotic if used earlier.  
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First line of second generation antipsychotic are indicated in the 
treatment of mania when rapid control of symptoms are required as in 
treatment of aggression, Lithium is indicated in classical euphoric mania 
and divalprox sodium is indicated when dysphoric or rapid cycling mania 
is present. rECT may be suggested if patient is very disruptive, not 
adequately responding to a combination of medications, has good ECT 
response in the past, pregnancy and those experiencing mixed episode. 
Psychosocial interventions like psychoeducation of patient and family 
and family focused intervention be started at the earliest. Psychosocial 
interventions like CBT or IPSRT, are also helpful. In rapid cycling 
BPAD, lithium or valproate may be used as the first line agents. Other 
mood stabilizers which can be considered include lamotrigine. If patient 
does not respond to monotherapy, then combination of mood stabilizers 
or a combination of mood stabilizer and antipsychotic medication may be 
considered. 
The maintenance treatment depends on the reproductive potential, 
comorbidities, tolerance, type of previous episodes, and preference of the 
patient. 
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METHODOLOGY 
Department of Psychiatry in government KMCH is a general 
hospital psychiatry unit providing Out patient and inpatient care.  
A total of 84 patients attending the Department of Psychiatry in 
Govt. Kilpauk Medical College, diagnosed as having a manic episode 
according to DSM-5 criteria , started on treatment by the consultant, are 
notified to the investigator .  
TYPE OF STUDY:  
Longitudinal study 
DURATION OF STUDY:  
12 months  
SAMPLE SIZE: 
Sample Size = 84  
Sample size n= Z22 / d2 
=73.8 days 
d=20% of mean= 16.1811 
Calculating, 1.962*73.82/ 16.18 
            = 79.92 = 80 
 5% non response =4 
     80+4=84    
  Confidence interval: 95%, Relative precision d= 20% of mean 
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INCLUSION CRITERIA: 
 Patients suffering from Manic episode (DSM-5 criteria) who are 
receiving pharmacological treatment 
   Age above 18 years 
   Patient gives informed consent 
EXLUSION CRITERIA: 
   Other Psychotic disorders (Schizophrenia spectrum and 
schizoaffective) 
   Organic mania 
   Substance induced mania 
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MATERIALS AND METHODS 
Patient fulfilling the inclusion criteria and are willing to give an 
informed consent and willing for regular follow up will be selected for 
the study. 
 After explaining the details of the study and obtaining an informed 
consent, a semi structured socio demographic proforma (Name, age, 
hospital no, gender, education, occupation, current occupational status , 
marital status, type of family) and Kuppuswamy socioeconomic status 
scale will be applied to participants.  
Information regarding any diagnosed mental illness in childhood, 
and Personality traits , course of the illness (age at onset, duration of 
illness, number of episodes, number of manic episodes in the past, 
number of depressive episodes in the past, type of previous episode, mean 
inter episodic interval, seasonality and illness characteristics in present 
episode (euphoria, dysphoria, Psychotic symptoms, aggression and 
irritability, duration of symptoms before seeking care), treatment during 
maintenance phase (lithium, Sodium valproate, Haloperidol, risperidone, 
others) is obtained from the attenders and verified from the records. 
YMRS and BPRS scores are obtained. Family support is assessed with 
Mac Masters Family assessment device. Stressors are assessed with 
PSLES scale. 
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 YMRS scale administered every third day until score 
becomes less than 4. When YMRS score is less than 4, a review of 
records and note of antipsychotics used in the current episode is made. 
After YMRS score becomes 4, Patient is assessed once in 2 weeks with 
YMRS scores for two months period. 
If YMRS is <4 for two months, it is considered that the patient has 
remitted and patient will be followed up monthly thereafter for a period 
of 6 months. During this period the regaining of functionality is assessed 
(occupational, social) by SOFAS scale. If Patient misses Follow-up, 
attempts will be made to contact the patient through the phone .No 
assumption will made about the disease status of patients who would miss 
the follow-up before remission.  
OUTCOMES AND DEFENITIONS: 
MANIA: 
As defined by Diagnostic and statical manual of Mental illness-5 
diagnostic criteria for manic  episode (296.40, 296.41, 296.42, 296.43, 
296.44) 12 
REMISSION:  
During the past 2 months, no significant signs or symptoms of the 
disturbance were present. Defined as YMRS scale score < or equal to 4 
for a period of 2 months 13 
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PRECIPITATING STRESSORS: The PSLES scale is the Indian 
adaptation of the Holmes and Rahe scale for assessment of stressful life 
events. It contains 67 events, that can increase the stress level in humans. 
An average of 2 life events per year and upto ten life events during life 
cycle occur in human life. The stressful life events, are identified as, 
‘stressors present’, if they occupy a position in the PSLES scale, and one 
or more of them is present ,within one month , preceding the onset of the 
manic episode. Any stressful life events other than those classified in 
PSLES scale and those in PSLES scale, occurring more than one month 
before the onset of the manic episode are classified as ‘stressors absent’ 
COMPLIANCE: Compliance is defined as the degree to which, the 
ptient follows the medical advice. It is measured directly by direct 
administration of medicine, measuring serum levels of the drug or 
indirectly by pill counts,therapeutic response, self report and proxy 
report. In our study, single item past 7 days scale ( Unni, Olson, Farris 
2013) is used, where the patient is asked to answer a single question,‘how 
many days in the past week have you been regularly taking all your 
medicines?’ An answer of 6 and 7 are coded as compliant and anything 
less than 6 days is coded as non compliant. 
FOLLOW UP: A follow up is defined as regular, if the patient has not 
missed more than 1 sheduled visit at a time ( once in a week in the 
symptomatic phase , once in 2 weeks at the maintenance phase, and once 
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in a month during follow up) at a time, not more than 2 times during the 
study period. Loss of more than one scheduled visit is coded as irregular. 
This coding is irrespective of patients procuring medications from other 
sources, in which case, they may be coded as compliant but irregular.  
Alcohol use: Alcohol use denotes any form of harmful use or dependence 
pattern of use with in the past 12 months before the onset of the index 
episode. Alcohol use was present in 44% of the patients prior to the 
illness  
TOOLS: 
YOUNG MANIA RATING SCALE ( YMRS): 
The Young Mania Rating Scale (YMRS) is one of the most frequently 
utilized rating scales to assess manic symptoms. The scale has 11 items 
and is based on the patient’s subjective report of his or her clinical 
condition over the previous 48 hours. Additional information is based 
upon clinical observations made during the course of the clinical 
interview. The items are selected based upon published descriptions of 
the core symptoms of mania. The YMRS follows the style of the 
Hamilton Rating Scale for Depression (HAM-D) with each item given a 
severity rating. There are four items that are graded on a 0 to 8 scale 
(irritability, speech, thought content, and disruptive/aggressive 
behaviour), while the remaining seven items are graded on a 0 to 4 scale. 
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These four items are given twice the weight of the others to compensate 
for poor cooperation from severely ill patients. There are well described 
anchor points for each grade of severity. The authors encourage the use of 
whole or half point ratings once experience with the scale is acquired. 
The scale is generally done by a clinician or other trained rater with 
expertise with manic patients and takes 15–30 minutes to complete. Inter-
rater reliability reported by the authors was adequate for total score (0.93) 
and for individual items ranged from 0.67 to 0.95. The validity of the 
scale was 0.86. The predictive validity was 0.6655. 
KUPPUSWAMY SOCIOECONOMIC STATUS SCALE 
Kuppuswamy socioeconomic status scale is a widely used scale to 
assess the socio-economic class of study participants. It was published in 
1981 originally, but modifications have been published regularly to 
account for the changing price index. It has three categories to be scored 
– education level of the head of the family, occupation of the head of the 
family and income per month. Education is scored from 1-7, occupation 
from 1-10 and monthly family income from 1-12. The total is added up. 
There are five socioeconomic classes that can be derived from the scale – 
upper (I), upper middle (II), middle/lower middle (III), lower/upper lower 
(IV) and lower (V). The scale needs modification from time to time 
because of the changing price index that affects the validity of the income 
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per month subset in the scale (Kuppuswamy B 1981, Kumar BR 2012, 
Sharma R 2014, Patro BK 2012)56.  
Brief Psychiatric Rating scale: 
The BPRS is a rating scale developed to characterize 
psychopathology and to measure change in clinical psychopharmacology 
research (Overall and Gorham, 1962). While the BPRS can be used for 
syndromes other than schizophrenia, it includes psychotic symptoms of 
greatest importance for assessing the clinical condition of schizophrenic 
patients. Originally developed with 16 items, the following standard  
18-item version has been used for more than 40 years (Guy, 1976), with 
each symptom rated on a severity scale of 1–7. Somatic concern, anxiety, 
depression, guilt, hostility, grandiosity, suspiciousness, hallucinations, 
unusual thought content, disorientation, conceptual disorganization, 
blunted affect, emotional withdrawal, motor retardation, tension, 
uncooperativeness, excitement, mannerisms and posturing. 
As its use expanded from monitoring an inpatient population, three 
new scales were added that might signal deterioration in an outpatient: (1) 
bizarre behavior; (2) self-neglect; and (3) suicidality. In addition, three 
scales to assess symptoms of importance in a manic phase of illness were 
added: (1) elated mood; (2) distractibility; and (3) motor hyperactivity 
(Lukoff et al., 1986)57. 
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Administration can take 10–40 minutes. We use the standard 18 
item version to assess the extent and severity of psychotic symptoms. 
Versions have been validated for use in both children and older adults 
(Kumra et al., 1996; McAdams et al., 1996)58. Reliability is expressed by 
intra-class correlation R = 0.78, for the total scale. Validity of the scale 
was R = 0.66. (John Anderson 2009) 
Mac Master FAD: 
The McMaster FAD, based on Mc Master Model of Family 
Functioning (MMFF), measures structural, organizational, and 
transactional characteristics of families. There are 6 scales that assess the 
6 dimensions of the MMFF - affective involvement, affective 
responsiveness, behavioral control, communication, problem solving, and 
roles . There is a 7th scale measuring general family functioning. The 
scale is comprised of 53 statements about a family. All family members 
aged twelve year, and more are asked to score how well each statement 
goes well with their own family. The FAD is scored by summing the 
responses (1-4) for each scale and dividing by the number of items in 
each scale (6-12). The response categories are Strongly agree, Agree, 
Disagree and Strongly disagree. It is a paper and pencil questionnaire and 
takes approximately 15-20 minutes to complete. 
The reliability of the scale Chronbach alpha is 0.72- 0.88 subscale 
wise and 0.92 for the general scale. The validity of the device is 0.67. 
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SOFAS ( Social and occupational functioning Assessment Scale): 
Luborsky operationalized the rating of functioning of an individual 
in a scale of 0-100, in the Health-Sickness Rating Scale. Health-Sickness 
Rating Scale was revised into a more functional version called the Global 
Assessment Scale (GAS) by Spitzer. The SOFAS is derived from the 
Global assessment scale. The SOFAS concentrates focusessolely on the 
individual's level of social and occupational functioning and the 
individual's psychological symptoms or its severity has no influence on 
the scoring, which makes it unique from the GAF scale. Any illness, 
either medical or psychiatric affecting the functioning is considered, 
while GAF considers only psychiatric illness.  
The SOFA score can tell of the functioning in the period of 
evaluation or sometime in the past. The scale considersa spectrum of 
functioning in the social and occupational domains, from superior to 
grossly impaired functioning. To be counted, impairment must be a direct 
consequence of mental and physical health problems; the impairments 
resulting from lack of opportunity and other environmental limitations 
should not be considered.91-100 denotes, Superior functioning in a wide 
range of activities, 81-90 marks good functioning in all areas, i.e., 
occupationally and socially effective. 71- 80 indicates no more than a 
slight impairment in social, occupational, or school functioning (e.g., 
infrequent interpersonal conflict, temporarily falling behind in 
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schoolwork) .61- 70 means Some difficulty in social, occupational, or 
school functioning, but generally functioning well, has some meaningful 
interpersonal relationships. 51- 60 persons have moderate difficulty in 
social, occupational, or school functioning (e.g., few friends, conflicts 
with peers or co-workers). 41- 50 indicates having serious impairment in 
social, occupational, or school functioning (e.g., no friends, unable to 
keep a job). 31- 40 marks major impairment in several areas, such as 
work or school, family relations (e.g., avoids friends, neglects family, 
unable to work; frequently beats up children, is defiant at home, and is 
failing at school). 21- 30 notes Inability to function in almost all areas 
(e.g., stays in bed all day; no job, home, or friends).In 11-20 patient 
Occasionally fails to maintain minimal personal hygiene and is unable to 
function independently. At1- 10 level patient has persistent inability to 
maintain minimal personal hygiene. Unable to function without harming 
self or others or without considerable external support  (e.g., nursing care 
and supervision). 0 means the information is not adequate. 
ETHICAL APPROVAL 
 Ethical approval for the study was obtained from the Ethics 
committee, Government Kilpauk Medical College, Chennai 
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RESULTS 
84 patients were enrolled in our study, within a period of 4 months. 
30.3% were treated on an outpatient basis and 63.1% were treated as 
inpatients at the enrollment in the study. An additional 6.6% of the 
patients were admitted at some point during the course of the episode. 
The follow up was regular in 67.9% of the patients and irregular in 
32.1%. Irregular patients were retained in the study, despite being coded 
irregular. The total sample (84 Patients) were available for the calculation 
of time to remission. 83 patients (one patient with very long time for 
remission could not be assessed SOFAS at 6 months post remission) were 
available for calculation of SOFAS score at 6 months post remission. 
SOCIODEMOGRAPHIC FACTORS:  
Age: The mean age of the sample was 32.88 years (SD 12.5 years) 
. The age group distribution was as follows: 
Table 5.1: Age group distribution of the sample 
Age group 14-
19y 
20-
29y 
30-
39y 
40-
49y 
50-
59y 
60-
69y 
70-
79y 
Percentage 11 37 27 13 7 4 1 
 
Sex distribution: 48.8% of the sample were males and 51.2% were 
females. The mean age of males in the sample was 35 years and females 
was 31 years.  
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Educational Status: 4.8% of the sample were uneducated, 22.6% 
had primary education, 51.2% had secondary education and 21.4% had 
higher education  
Occupational status: 27.4% were unemployed (14.3 % were 
housewives) 27.4% unskilled labours, 28.6% semiskilled, 15.5% were 
skilled workers (3.6% were students)  
Socio economic status: 27.4% were of low SES, 51.2% middle SES, and 
21.4% high SES.  
Marital Status: 38.1% were single, 57.2% were married, 4.8% 
separated or divorced  
     Family type: 73.8% were from nuclear families and 26.2 % had 
extended nuclear or joint family setup  
     Family Support: The family support was healthy in 69% of the sample 
and unhealthy in 31% of the sample. 
 Childhood disorders: Recognized childhood disorders were 
present in 6% ( ADHD-1, SLD-1, ODD-1. None were on any 
pharmacotheraphy) and 94% of the sample did not have any recognized 
childhood disorders. 
Trait Characteristics: 28.6% of the population were extroverts, 
54.8% ambiverts and 16.7% were introverts. 50% of the sample showed 
openness to new experiences whereas the other half was conservative. 
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Family history: A significant proportion of patients had a family 
history . 79.8% had mental illness or suicides in the family and 20.2 % 
did not have a family history of mental illness. In 45.3% of the 
population, mother had some form of mental illness at some point in their 
lives (81% type of illness not known, 9% had mood disorder, 9% had 
suicides with out diagnosed mood disorder. 3% had psychosis).  
In 10.6 %, fathers had psychiatric illness of which 14% were 
mood, 28% were suicides and 42% were ADS. In 5 % of patients, 
siblings had mental illness. Multiple family members ( including cousins, 
aunts and grandparents) had history of mental illness in 9.6% of the 
patients. The status unknown usually included post partum events and 
transient psychotic events and behavioural problems which lasted a week 
or more. 
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Table 2: Socio Demographic Characteristic of the Sample 
Variable Mean 
(SD) 
Percentage 
(%) 
1.Age 32.88 
(12.5) 
 
  Male 35  
  Female 31  
2.Gender   
  Male  48.8 
  Female  51.2 
3.Education   
  Uneducated  4.8 
` Primary  22.6 
  Secondary   51.2 
  Higher  21.2 
4.Occupation   
  Unskilled  27.4 
Semi-skilled  28.6 
  Skilled  15.5 
  Unemployed (House 
wife) 
 27.4 (14.3) 
5.Socio-economic 
Status 
  
  Lower  27.4 
  Middle  51.2 
  Upper  21.4 
6.Marital Status   
  Married  57.2 
  Single  38.1 
  Separated  4.8 
7.Family type   
 Nuclear  73.8 
  Extended nuclear and 
Joint 
 26.2 
8.Family support   
  Healthy   69.0 
  Unhealthy 
 
 31.0 
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Table 5.3: Personal and family history of sample population: 
Variable Percentage (%) 
1.Childhood disorders  
Present 6 
Absent 94 
2.Trait Characteristics  
Version (Extrovert/ 
Ambivert/ Introvert) 
28.6/54.8/16.7 
Openness/ 
Conservativeness 
50/50 
3.Family History  
Absent 20.2 
Present 79.8 
4.Type of illness in the 
family 
 
Mood Disorder 9.5 
Psychosis 4.8 
Suicide 10.7 
Alcohol Dependent 3.6 
Status unknown 51.2 
5.Alcohol Use  
Present 44 
Absent 66 
 
CURRENT EPISODE CHARACTERISTICS OF THE SAMPLE:  
Substance use in current episode: 46.7% of the patients used alcohol in 
the current episode. Cannabis use was present in 7.1% of the population. 
Other substance use including nicotine and smokeless tobacco was found 
in 22.6% of the sample. 
Type of episode: 51.2% had euphoric mania, 41.7 % had dysphoric type 
and 7.1% had mixed episodes. Psychotic symptoms were present in 
45.2%. Irritability and aggression were present in 57.1% of the patients.  
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Precipitating stressors: Precipitating stressors were present in 45.2% 
patients. It was mostly related to threat or loss. 
Period of symptoms before hospitalization: The mean duration of 
symptoms in the current episode, before contact with mental health 
services was 35.6 days ( SD 56.9 days). The median value was 17.5 days. 
( 1 st episode-44 days, 2nd episode-34 days, 3rd episode-42 days, 4th 
episode-19 days, 5th episode-16 days and multiple episodes-31 days). 
50% of the patients were hospitalized before 15 days of illness and 75% 
before 30 days. Based on the values obtained, we classified the period 
before hospitalization as Short- 0 to15 days, Medium- 16 to 60 days, 
Long 61-120 days and very long- greater than 120 days.  
YMRS score: The minimum YMRS score was 12 and maximum was 48. 
Mean YMRS score of the sample population was 25.65 and SD was 8.32.  
BPRS score: The mean BPRS score of the sample was 22.6 (SD 12.1) 
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Table 5.4: Current episode characteristics of the sample 
Substance use in current episode Percentage 
Alcohol use  
 Present 46.7 
Absent 53.3 
Cannabis use  
 Present 7.1 
 Absent 92.9 
Other substance use  
 Present 22.6 
 Absent 77.4 
Type of episode  
 Euphoric  51.2 
 Dysphoric 41.7 
 Mixed 7.1 
Psychotic Symptoms  
 Present 45.2 
 Absent 54.8 
Irritability and Aggression  
 Present 57.1 
 Absent 42.9 
Precipitating stresses   
 Present 45.2 
 Absent 54.8 
Duration of illness 
Before contact with MHS ( Mean,SD) 
35.6 (56.9) 
YMRS Score (Mean, SD) 25.65 (8.32) 
 
ILLNESS CHARACTERISTICS OF SAMPLE POPULATION: 
Age at onset: The mean age at onset of the illness was 26.9 years (SD 
8.35). 50% of the sample had onset between 21.5 and 30.1 years. The 
mean duration of illness of the sample population was 71.7 months ( IQR 
3-93 months) . The median was 24 years.  
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Figure 1: Age at onset distribution 
 
 
 
Number and type of previous episodes: The mean number of previous 
episodes in the sample population was 3.02 (SD 5.63). The mean number 
of episodes in males were 3.59 (SD 6.53) and females 249 (SD 4.63). 
28.6% were of first episode, 23.8% in the second episode, 17.9% in the 
third episode, 9.5% in the fourth episode, 4.8% in fifth episode, 3.6% in 
the 6th episode, 1.2% respectively in 7th, 8th and 9th episodes, 6% had 
greater than 10 episodes. More than 5 episodes is labelled as multiple 
episodes in our study. 
Previous episode:In 38.1 % the previous episode was manic, in 28.6% 
the previous episode was depression and in 3.6% the previous episode 
was mixed.  
Seasonality: Seasonality was present in 4.8 percent of the study 
population.  
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Co morbid Medical illness: Co morbid medical illness is present in 
20.2% of the sample. 3.6% had diabetes, 3.6% had hypertension, 2.4% 
had obesity and triglyceridemia, 3.6% had a combination of these medical 
illness, 1.2% had hypothyroidism, 4.8% had other medical illness. 
Treatment setting: 30.3% were treated on an outpatient basis and 63.1% 
were treated as inpatients at the beginning of the treatment. An additional 
6.6% of the patients were admitted at some point during the course of the 
illness. The mean hospitalization was 8 days with standard deviation of 9 
days. There was no significant difference in the number of IP care days 
with progressive number of episodes.  
Followup and Compliance: The follow up was regular in 67.9% of the 
patients and irregular in 32.1%. 78.6% were compliant to medications 
and21.4 % were non compliant. 
Medication History: 60.1 % were not on any medication previously, 
23.9% were on single drug maintenance, 13.2% on 2 drugs and 2.4% on 
three drugs in the maintenance phase before the onset of illness. 2.4 % 
developed manic switch while on antidepressant treatment. 16.7%, 8.4%, 
10.8% received valproate and formulations, lithium and risperidone alone 
or in combination in the maintenance. Other antipsychotics used were 
haloperidol (6%) olanzapine (3.6%), aripiprazole (1.2%), 
quetiapine,trifluperazine (1.2%). 
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Interepisodic interval: The intercycle interval in multiple episode 
patients ( between the beginning of the previous episode and the current 
episode) is 18.63 months ( SD 34.3 months). 50 th percentile is 12 
months.  
Table 5.5: Illness characteristic of the sample population 
 Mean  Percentage 
1.Age at onset (years) 26.9 (SD8.32)  
2.Duration of illness (Months) 71.7  
3.Episodic distribution   
1st Episode  28.6 
2nd Episode  23.8 
3rd Episode  17.9 
4th Episode  9.5 
5th Episode  4.8 
Multiple Episode  15.5 
4.Mean No. of Previous 
episode 
3.02  
Male 3.59  
Female 2.4  
5.Seasonality   
Present  4.8 
Absent  95.2 
6.Co morbid Medical illness   
Present  20.2 
Absent  79.8 
7.Follow up and compliance   
Regular  67.9 
Irregular  32.1 
Compliance  78.6 
Non compliance  21.4 
8.Previous drugs   
No Drugs  60.1 
1 Drug  23.9 
2 Drugs  13.2 
3 Drugs  2.4 
9.Inter cycle length 
 (months) 
18.63 (34.3)  
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Relation between Socio Demographic and Illness Variables: 
Gender differences in variables: There was no significant difference in 
both sexes of the type of episode, presence or absence of psychotic 
symptoms, aggression and irritability, precipitating stressors, family type, 
family support, follow up regularity and drug compliance 
Gender differences in marital status among manic patients: There was 
no significant differences in marital status across gender. In other words, 
bipolar illness did not significantly affect the marital status in our 
population. 
Table 5.6: Effect of Gender on marital status of manic patients 
Gender Single Married 
Seperated or 
divorced 
Chi square 
Male 14 25 2 0.536 
P=0.765 Female 18 23 2 
p value is significant at the 0.05 level 
No difference in trait characteristics was noted across gender. 21% 
of males and 34% of females were extroverts, 56% of males and 53% of 
females were ambiverts, 21% of males and11.6 % of females were 
introverts. (p=0.273) 
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48.7% of males and 51.1% of the females showed openness to new 
experiences, whereas 51.3% of males and 48.9% females were 
conservative. (p= 0.827) 
No significant difference is noted across the gender in the family 
history of mental illness.  
Table 5.7: Family History of Mental illness between gender 
Gender Family History  
Gender Absent Present Chi square 
Male 11 30 2.156 
P=0.142 Female 6 37 
p value is significant at the 0.05 level 
Substance use across gender: Clinically significant difference is noted in 
the use of substances (alcohol/ Cannabis/ Other substances) across the 
gender. Males showed higher abuse of substances. Cannabis use was 
found exclusively in males, alcohol use in current episode was found in 
4.6% of females and 51.2% of males. Other substances including nicotine 
and SLT was present in 34.1% males and 11.6 % of females. All types of 
substance use were significantly higher in males both in the episode as 
well as independent of the episode. 
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Episode characteristic : There was no significant difference in the type 
of episode (euphoric, dyphoric or mixed), presence or absence of 
psychotic symptoms or aggression across genders. 
Table 5.8 : Effect of Gender on Episode Characteristics: 
Type of episode Euphoric Dysphoric Mixed Chi square 
Male 21 17 3 0.004 
P=0.998 Female 22 18 3 
Psychotic symptoms Present Absent Chi square 
Male 16 25 1.248  
 
P=0.264 
Female  22 21 
Irritability/aggression    
Male 16 25 0.480 
P=0.488 Female  20 23 
 p value is significant at the 0.05 level 
Stressors: There was no significant difference in the occurrence of 
precipitating stressors in males and females.56.09% of males and 51% of 
females had precipitating stressors. (p=0.583) 
Age at onset: There was no difference in the age of onset between males 
and females. Age of onset is 23.3years (SD 8.8) in males, and 25.35 years 
(SD 7.6)  (P=0.09) 
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Inter cycle length: No significant difference in intercycle length was 
noted across genders, 17.22 months (SD31.02) in males, and 20.00 
months (SD 37.57) in females. (p=0.714) 
Seasonality: Seasonality was present more in males and absent in the 
female sample. However the difference was not significant. 
Table 5.9 : Effect of Gender on seasonality: 
Gender Absent Present Fishers exact 
Male 37 4  
P=0.052 Female  43 0 
p value is significant at the 0.05 level  
Follow up: No significant difference in regularity of followup was noted 
between genders 
Table 5.10: Effect of Gender on Followup 
Gender Irregular Regular Chi square 
Male 10 31 2.230 
P=0.328 Female  16 27 
p value is significant at the 0.05 level  
Compliance: No significant difference in compliance was noted among 
males and females 
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Table 5.11: Effect of Gender on Compliance 
Gender Compliance  Non-
Compliance 
Chi square 
Male 31 10 1.725 
P=0.422 Female  36 7 
p value is significant at the 0.05 level  
Period before contact with MHS: Gender differences in period of 
symptoms before contact with mental health services: The mean duration 
of symptoms before contact with mental health services in the current 
episode was48.37 (SD 70.01) days in males whereas it was only 23.42 
(SD 37.68) days ( p= 0.018) 
Table 5.12: Effect of Gender on Period before contact with 
MHS: 
      Sex 
Period BH 
Male Female Chisquare 
Short 15 27  
9.107 
P= 0.028 
Medium 11 9 
Long 7 6 
Very long 8 1 
p value is significant at the 0.05 level 
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Gender difference in Time taken for remission: The time taken for 
remission was higher for males, when compared to females. 
Table 5.13: Effect of Gender on Time to remission: 
Sex Time taken for remission Levenes t test 
Mean SD 
Male 102.51 48.23 2.880 
P=0.093 Female 81.56 27.66 
 
p value is significant at the 0.05 level 
Gender difference in SOFAS Score: The SOFAS score at 6 months was 
72.65 for males and 75.33 for females. 
Table 5.14: Effect of Gender on Functioning 6 months: 
Sex SOFAS score at 6 months Levenes t test 
Mean SD 
Male 72.65 16.21 1.926 
P=0.169 Female 75.33 11.57 
p value is significant at the 0.05 level 
Effect of age difference on variables: Age category Vs family support: 
The family support did not differ significantly across different age group 
of patients. 
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Table 5.15: Effect of Age on family support: 
Age group Family support Chisquare/P 
value Healthy Unhealthy 
14-30 33 13 9.23 
P=0.623 31-50 20 9 
51-80 5 4 
p value is significant at the 0.05 level 
Age category Vs Stressors: There was no difference in the presence of 
precipitating stressors across age group 
Table 5.16: Effect of Age on precipitating stressors: 
Age group Absent Present 
Chisquare/P 
value 
14-30 27 19 0.782 
P=0.676 31-50 15 14 
51-80 4 5 
p value is significant at the 0.05 level  
Age Vs Period before contact with MHS: The period of symptoms before 
contact with MHS was shorter for younger age group, whereas it 
increased with progressing age. 
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Table 5.17: Effect of Age on Period before contact with MHS: 
Age Category Period before 
hospitalization 
ANOVA 
P value 
14-30 21 7.894 
P=0.001 31-50 40 
51-80 97 
p value is significant at the 0.05 level  
Age category Vs seasonality: There was no significant difference in 
seasonality across age groups.  
Table 5.18: Effect of Age on seasonality: 
Age category Seasonality Fishers exact 
Absent Present 
14-30 46 0 50.09 
P=0.078 31-50 26 3 
51-80 8 1 
p value is significant at the 0.05 level  
Table 5.19: Alcohol use across age group in bi-polar patients 
Age group Absent Present Chisquare/P value 
14-30 36 10 2.249 
P=0.325 31-50 20 9 
51-80 5 4 
p value is significant at the 0.05 level  
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There was no significant difference in the alcohol use across age groups 
of bipolar patients. 
Age Vs current substance use : There was no significant difference in 
alcohol use (p=0.177), cannabis use (p=0.886), or other substance use 
(p=0.054) in the current episode across age groups. 
Age cat Vs episode characteristics: There was no significant difference 
in the type of episode across age groups 
Table 5.20: Effect of Age on episode type 
Age  
Group 
Euphoric Dysphoric Mixed Chisquare/P 
value 
14-30 22 20 4 4.657 
P=0.324 31-50 14 14 1 
51-80 7 1 1 
p value is significant at the 0.05 level 
Age category Vs Psychotic symptoms: There was no significant 
difference in the presence or absence of psychotic symptoms across age 
group. 
Table 5.21: Effect of Age on psychotic symptoms 
Age  Group Absent Present Chisquare/P value 
14-30 24 22 0.641 
P=0.746 31-50 16 13 
51-80 6 3 
 p value is significant at the 0.05 level  
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Age category Vs irritability and aggression: There was no significant 
difference between the age groups in the presence or absence of 
irritability and aggression. 
Table 5.22: Effect of Age on Irriatbility and aggression 
Age  Group Absent Present Chisquare/P value 
14-30 21 25 0.443 
P= 0.801 31-50 11 18 
51-80 4 5 
p value is significant at the 0.05 level  
Age category Vs drugs in maintenance phase: Patients under age group 
of 30 years were not on maintenance medication mostly, while those 
greater than 30 years age were on average on one drug in the maintenance 
phase. 
Age category Vs Regularity: Increasing regularity was found with 
increasing age, which was probably related to increased number of 
episodes in the past (58% in the 14-30 year group versus 82% in 31- 50 
year age group and 77% in > 50 year age group (p= 0.075)) 
Effect of age on time to remission: 
The time to remission was not significantly different among 
different age groups. 
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Table 5.23: Effect of Age on Time Taken to remission: 
Age category Time to remission P value 
 Mean SD 
14-30 85.44 24.63 1.026 
 (0.363) 
 
31-50 88.21 34.07 
51-80 109.67 47.56 
p value is significant at the 0.05 level  
Effect of age on social and occupational functioning: The SOFAS score 
at 6 months was lesser with increasing age which was statistically 
significant 
Table5.24: Effect of Age on SOFAS: 
Age category SOFAS at 6 months P value 
 Mean SD 
14-30 77.98 9.12 13.98 
 (0.00) 31-50 74.00 11.9 
51-80 54.44 22.97 
p value is significant at the 0.05 level 
Effect of education on variables:  
Education Vs period of symptoms before contact with MHS: There was 
no significant difference in the duration of symptoms before contact with 
mental health sevices in the current episode, with respect to the 
educational status of the patient. 
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Table 5.25: Effect of Education on Period before contacting MHS: 
Education Uneducated Primary 
Education
Secondary 
education 
Higher 
education 
ANOVA
Period before 
MHS contact 
39 33 34 41 0.076 
P=0.973
p value is significant at the 0.05 level 
Education vs YMRS: Education did not have any effect on the illness 
severity at which mental health services are contacted. 
Table 5.26: Effect of Education on illness severity at first contact: 
YMRS 
score 
 
Uneducated 
Primary 
Education
Secondary 
education 
Higher 
education 
ANOVA
Mean 
YMRS  
24 27 27 23 0.914 
P=0.438 
p value is significant at the 0.05 level  
Table 5.27: Effect on Education on Followup 
Follow up 
Educational Status Fishers 
exact Uneducated Primary Secondary Higher  
Irregular 2 6 16 2 5.107 
P=0.162 Regular 2 13 27 16 
p value is significant at the 0.05 level  
There was no significant difference in the regularity of followup with 
educational attainment. 
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Education vs Compliance:There was no significant differences in 
compliance across various educational groups. 
Table 5.28: Effect of education on Compliance 
    
Compliance 
Educational status Fishers 
exact Uneducated primary Secondary Higher 
Non 
compliant 
2 4 7 4 2.833 
P=0.380 
Compliant 2 15 35 14 
p value is significant at the 0.05 level  
Education Vs time to remission:Educational status did not have any 
influence on the time taken for remission 
Table 5.29: Effect of education on Time to remission 
Education 
 
Uneducated Primary 
Education
Secondary 
education 
Higher 
education 
ANOVA
Time taken 
for 
remission 
(days) 
91 92 90 95 0.061 
P=0.980 
p value is significant at the 0.05 level  
Education Vs SOFAS: The SOFAS score at 6 months post remission was 
not significa ntly affected by educational status. 
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Table 5.30: Effect of education on functioning at 6 months 
Education 
 
Uneducated Primary 
Education 
Secondary 
education 
Higher 
education 
ANOVA 
SOFAS 
score at 6 
months 
65 76 75 73 0.736 
P=0.533 
p value is significant at the 0.05 level  
Effect of Occupational Status on Variables:  
Occupational status versus Stressors: The increasing complexity of work 
is assosciated with stressor related precipitation of the episode 
Table 5.31: Relationship between Occupation status and 
precipitating stressors: 
Occupation 
Vs Stressors 
Unemployed Housewife Unskilled Semiskilled Skilled 
Chi 
square 
Present 1 8 13 11 5 9.465 
P= 
0.050 
Absent 10 4  10 14 8 
p value is significant at the 0.05 level  
Effect of occupational status on time to remission: Occupational status 
did not significantly affect time to remission 
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Table 5.32: Effect of occupation on time to remission: 
Occupation Unemployed Housewife Unskilled Semiskilled Skilled ANOVA 
Time 
taken for 
remission 
93 70 82 106 102 2.305 
P=0.066
p value is significant at the 0.05 level 
 
Effect of occupational status on functioning at 6 months: The SOFAS 
score at 6 months did not differ significantly with the occupational status. 
Table 5.33: Effect of occupation on functioning at 6 months: 
Occupational 
status 
Unemployed Housewife Unskilled Semiskilled Skilled ANOVA 
SOFAS at 
6m 
73 81 74 71 74 1.038 
P=0.393 
p value is significant at the 0.05 level  
Effect of SES on Variables: The Socio economic status did not have any 
significant effect on the type of episode, presence or absence of psychotic 
symptoms or irritability and aggression. 
Table 5.34 : Effect of Socio Economic Status on Aggression: 
  
   SES  
Irritability and aggression Chisquare 
Present Absent 
Low 9 14 0.537 
P=0.764 Middle  26 17 
High 13 5 
p value is significant at the 0.05 level  
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The mean number of days before contact with mental health services did 
not vary significantly across socioeconomic classes. 
Table 5.35 : Effect of Socio Economic Status on  
Period of symptoms before contact with MHS: 
SES Period before contact with MHS 
(Mean no. of days) 
 
ANOVA 
Low 31 0.498 
P=0.610 Middle  42 
High 27 
p value is significant at the 0.05 level 
No significant difference was noted in the mean number of 
previous episodes across SES.  
Effect of SES on time to remission: The time taken for remission was not 
significantly different among socioeconomic classes 
Table 5.36: Effect of Socio Economic Status on Time to remission: 
SES Time taken for remission ( Mean number of days) 
  ANOVA 
Low 92  1.363 
P=0.262 Middle  86 
High 105 
p value is significant at the 0.05 level 
Effect of SES on functioning at 6 months: The SOFAS score at 6 
months did not vary with socioeconomic status. 
 61
Table 5.37: Effect of Socio Economic Status on  
Functioning at 6 months 
SES SOFAS ( Mean score) ANOVA 
Low 75 0.076 
P=0.926 Middle  74 
High 73 
p value is significant at the 0.05 level  
Effect of family type on variables: There period of symptoms before 
contact with mental health services was 38.32 in nuclear family and 27.91 
in joint family (p= 0.103). The intercycle length was 17.81 in nuclear 
family and 21.05 in joint family (p=0.67). The mean number of days of 
IP care was 8.67 in nuclear family and 6.27 in joint family (p=0.182).  
Family type had no significant influence on the episode 
characteristics, psychotic symptoms and aggression. Family type did not 
influence followup or compliance.  
The time taken for remission was longer in the nuclear family groups, but 
the difference was not statistically significant. 
Table 5.38: Effect of Family type on Time to remission: 
Family type 
Time taken for 
remission 
P value 
Nuclear  96 (43.57) 0.126 
Extended nuclear and 
Joint 
79 (26.19) 
p value is significant at the 0.05 level 
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Effect of family type on Functioning: The SOFAS score was higher in 
the joint family samples. 
Table 5.39:Effect of Family type Functioning at Six months 
Family type SOFAS at 6 m P value 
Nuclear 73.18 (14.82) 0.513 
Extended nuclear and 
Joint 
76.41 ( 11.30) 
p value is significant at the 0.05 level  
Effect of family history on Variables: The presence of family history 
did not have any influence on the type of episode or presence of 
irritability and aggression.  
The presence of family history is significantly associated with the 
presence of psychotic symptom. 89% of those with a family history had 
psychotic symptoms whereas only 71% of those without a family history 
had psychotic symptoms. 
Table 5.40: Influence of Family History on Psychotic symptoms: 
Psychotic   
symptoms 
Family History 
Chi square 
Present Absent 
Present 34 4 4.055 
0.044 a bsent 33 13 
p value is significant at the 0.05 level  
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The period of symptom before hospitalization was 21.41 (SD 19.6) 
days in the group with no family history, whereas it was 39.19 (SD 62.56) 
days in those with a family history. However the difference is not 
statistically significant. 
No difference is noted in the age at onset in patients with and 
without family history (27.01 ( SD 8.60) Vs 26.09 (SD 7.48) 
No difference is noted in the frequency of episodes  ( number of 
episodes opposed to duration of illness) in the patients with and without a 
positive family history 
There was no difference in regularity of followup in both groups. 
However, the compliance was higher in the group of patients who had a 
history of familial mental illness. 
Table 5.41: Effect of Family history on compliance 
 
Compliance 
Family history Chi square 
Present Absent 
Present 58 9 9.498 
P=0.002 Absent 9 8 
p value is significant at the 0.05 level 
  The mean YMRS score did not differ among those with and 
without a family history.  
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The time taken for remission was shorter in those patients without 
a family history of mental illness, and the average time is higher for those 
with a positive family history.But the difference was not statistically 
significant. 
Table 5.42: Effect of Family history on Time to remission: 
Family history Time taken for remission 
Mean (SD) 
T test 
Present 95.0 ( 41.64) P=0.147 
Absent 79.12 ( 32.15) 
p value is significant at the 0.05 level 
The SOFAS score at 6 months post remission was higher in those 
with a negative family history and those with a positive family history 
had a lower level of functioning as evidenced by lower SOFAS score 
which is statistically significant. 
Table 5.43 Effect of Family history on Functioning at Six months: 
Family history SOFAS at 6 months 
Mean (SD) 
T test 
Present 72.65 ( 14.84) P=0.075 
P= 0.016 absent  79.41 ( 8.26) 
p value is significant at the 0.05 level 
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Effect of alcohol use on variables: Alcohol use independent of episodes 
did not have any effect on the age of onset of bipolar disorder. Both 
group of patient had mean age of onset at 27 years. The intercycle length 
was not affected by alcohol use ( 18.75 months in non users Vs 18.30 
months in users). Alcohol use did not have any significant effect on the 
type of the episode, presence or absence of psychotic symptoms or 
presence or absence of irritability and aggression. The mean number of 
previous episodes in the non use group was 2.49 ( 5.34) and in the alcohol 
use group was 4.04 (6.27) (p= 0.12) 
The period of symptoms before contact with the mental health 
services are longer when alcohol use is present. But the difference is not 
statistically significant. 
Table 5.44: Effect of alcohol use on symptoms  
before contact with MHS 
Alcohol use Period before contact 
with MHS 
P value 
Absent 29.30 (47.67) 0.150 
Present 52.30 ( 74.93) 
p value is significant at the 0.05 level 
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The time taken for remission was higher in the alcohol use group. 
However the difference is not statistically significant. 
Table 5.45: Effect of Alcohol use on time to remission: 
Alcohol use Time taken for remission P value 
Absent 87.21 (31.22) 0.103 
Present 103.91 (56.91) 
p value is significant at the 0.05 level 
The SOFAS score at 6 months was significantly lower in the 
alcohol use group as compared to the non alcohol use group.  
Table 5.46: Effect of Alcohol use on Functioning at Six months 
Alcohol use SOFAS score at 6 months 
Mean 
P value 
Absent 75.15 0.003 
Present 70.95 
p value is significant at the 0.05 level 
YMRS Score: The mean YMRS score in the current episode is 
25.88 ( SD 8.1). There was no significant difference in the YMRS in the 
male and female group as well as across episodes.  
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Table 5.47: YMRS Scores across episodes: 
Episode 
number 
1 2 3 4 5 Multiple 
YMRS 29 25 28 25 19 23 
 
There was no significant correlation between, the period of 
symptom before hospitalization and YMRS scores. No correlation was 
found between the YMRS score and the time taken for remission or the 
SOFAS score at 6 months. 
Effect of Episode Characteristics on the Variables: 
The type of episode (Euphoric / Dysphoric or Mixed) was not 
influenced by age at onset, duration of illness, number of previous 
episodes, intercycle length. 
The YMRS score at admission or the duration of symptoms before 
contact with MHS is not influenced by the type of the episode 
The type of episode did not alter the Time taken for remission or 
the SOFAS score at 6 months post remission significantly 
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Table 5.48: Effect of episode type on time to remission: 
Variables              Type of episode ANOVA 
P value Euphoric Dysphoric Mixed 
Time taken for 
remission 
Mean ( SD) 
88.83 
 (32.67) 
89.46 
 (32.48) 
88.00 
 (20.24) 
0.853 
SOFAS at 
months  
Mean (SD) 
73.10 
 (15.12) 
75.94 
 (11.37) 
71.00 
 (19.83) 
0.484 
p value is significant at the 0.05 level 
Psychotic symptoms: The presence of Psychotic symptoms was not 
influenced by the duration of illness, number of previous episodes, 
intercycle length or the period of symptoms before hospitalization. The 
presence of a family history of mental illness increased the probablility of 
having psychotic symptoms in the current episode. 
The presence or absence of Psychotic symptoms did not have any 
significant effect on the time taken for remission or the SOFAS score at 6 
months post remission 
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Table 5.49: Effect of Psychotic symptoms on  
Time to remission and functioning 
Variables Psychotic symptoms  
P value Absent Present 
Time for remission 91.00 92.44 0.509 
SOFAS at 6 months 74.11 73.95 0.602 
p value is significant at the 0.05 level 
Irritability and Aggression: The presence or absence of irritability or 
aggression was not influenced by the age at onset, duration of illness, 
number of previous episodes or intercycle length.  
The period before contact with mental health services is 
significantly delayed by the presence of irriatability and aggression. 
Correspondingly the YMRS score at admission is higher in such patients. 
Table 5.50: Effect of Aggression on contact with  
MHS and YMRS course 
Variables Irritability/ Aggression T test 
P value Absent Present 
Period before 
contact with MHS 
(Mean No of Days) 
23.11 44.96 0.004 
YMRS ( Mean) 23.39 27.75 0.017 
p value is significant at the 0.05 level  
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The time taken for remission and the SOFAS score at 6 months 
post remission, did not vary significantly between the groups. 
Table 5.51: Effect of Aggression on  
Time to remission and functioning: 
Variables Irritability and aggression T test 
P value Absent Present 
Time for remission 88.9 94.60 0.541 
SOFAS at 6 mo nths 74.23 73.90 0.928 
p value is significant at the 0.05 level 
Effect of stressors on variables: The age at onset , duration of illness, 
number of previous episodes or intercycle length did not predict the 
current episode having a precipitating stressor. 
Howerver the time to contact with MHS was significantly higher in 
the presence of precipitating stressors.  
The presence of precipitating stressors resulted in a delay in 
contact with MHS. 
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Table 5.52: Effect of Stressors on contact with MHS 
Variables Stressors T test 
P value Absent Present 
Period before 
contact with MHS 
44.46 
 (73.03) 
28.11 
 (78.22) 
0.022 
p value is significant at the 0.05 level  
The precipitating stressors, did not have any significant effect on 
the time taken for remission or SOFAS score at 6 months post remission. 
Table 5.53: Effect of Stressors on Time to remission and 
Functioning at Six months: 
Variables 
Stressors T test 
P value Absent Present 
Time for remission 91.98 
 (47.71) 
91.55 
 (29.39) 
0.178 
SOFAS at 6 months 73.58 
 (15.80) 
74.58 
 (12.40) 
0.570 
p value is significant at the 0.05 level 
Age at onset: The age at onset did not have any significant correlation 
with the time taken for remission or the SOFAS score at 6 months post 
remission. Significantly greater number of patients with a later age of 
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onset of the disease, showed a longer time to remission, compared to 
those with a lesser age at onset. (p=0.044). 
Duration of illness: The duration of illness did not have any correlation 
with the time taken for remission. The duration of illness was inversely 
correlated with the SOFAS score at 6 months post remission (r = -0.527, 
p =0.00) 
Number of previous episodes: The number of previous episodes did not 
have any significant correlation with the time taken for remission. The 
SOFAS score at 6 months post remission was inversely correlated to the 
number of previous episodes (r = -0.394. p=0.00) 
Table 5.54: Episode wise Time to remission: 
Episode number Vs time taken for remission ANOVA 
P value Episode 
number 
Time taken for remission 
Mean SD Median 
1st episode 84.13 58.77 71.00  
0.591 
P=0.172 
2nd episode 77.50 16.98 78.50 
3rd episode 97.73 30.32 101.0 
4th episode 105.38 27.47 116.50 
5th episode 97.00 42.85 98.50 
Multiple 
episodes 
111.0 33.38 106.0 
p value is significant at the 0.05 level  
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Type of previous episode: The intercycle length was affected by the type 
of previous episode. The intercycle interval was short when the previous 
episode was depression and long when the previous episode was mania. 
Table 5.55: Effect of Previous episode on inter episodic interval 
Type of previous 
episode 
Intercycle length ANOVA 
P value 
Mean SD Median 
Mania  27.18 29.46 24 7.882 
P=0.00 Depression 16.36 25.63 12 
Mixed 74.00 112.62 12 
p value is significant at the 0.05 level 
 The nature of previous episode did not affect the time taken for 
remission. 
Table 5.56: Effect of Previous episode  
Characteristics on time to remission 
Type of previous 
episode 
Time taken for 
remission 
Mean (SD) 
Time taken for 
remission 
Median 
ANOVA 
P value 
Mania 84.14 (26.40) 86.50 1.96 
P=0.125 Depression 106.21 (30.73) 111.0 
Mixed 97.0 (27.63) 94.0 
p value is significant at the 0.05 level 
 However, When the previous episode was manic, 3.5% showed 
long and 32.1% showed medium time to remission, whereas when the 
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previous episode was depression, 21% took long time and 46% took 
medium time to remission (p=0.004) 
Intercycle length: The intercycle length was not affected by the age of 
onset, duration of illness or number of previous episodes or type of 
previous episode. The intercycle length did not have any significant 
correlatrion with the time taken for remission or the SOFAS score at 6 
months post remission.  
Effect of seasonality on Variables: The seasonal pattern of illness did not 
vary significantly from the non seasonal type in the age at onset 
(p=0.356) or the illness severity ( YMRS score) at presentation ( 0.067). 
There was no significant difference in the time to remission in the 
seasonal mania group, but the SOFAS score at 6 months post remission is 
significantly lower in the seasonal group. 
Table 5.57 : Effect of seasonality on remission and functioning 
Variable Seasonality T test 
P value Absent Present 
Time taken for 
remission 
92.53 
 (41.86) 
77.80 
 (10.4) 
0.141 
SOFAS at 6 
months 
74.68 
 (13.0) 
61.25 
 (25.94) 
0.013 
p value is significant at the 0.05 level 
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TIME TAKEN FOR REMISSION: 
The mean time taken for remission was 91.79 days (SD 40.2 days). 
The median is 89 days with an inter quartile range of 66.2-114.7 days. 
The shortest time taken for remission is 35 days and the longest time 
taken for remission of a single manic episode was 320 days. The mean 
time taken for remission in males was 103 days and females was 82 days. 
The mean time was 73.87 days ( SD 31.19) in the first episode, 
77.50 ( SD 16.98) in the second episode,97.73 days for the third episode 
(SD 30.32), 105.38 ( SD 27.47) for the fourth episode, 97 days (SD 
42.85) in fifth episode and 111.08 ( SD 33.38) in multiple episodes. 
(p=0.172)  
The mean time taken for remission in the first episode in males is 
106 days (SD 48.2) and females was 58 days (SD 27.6) (p=0.016). The 
median time taken for remission in first episode males was 84 days and 
females is 57 days. The time taken for remission is significantly different 
among the males and females in the first episode,but not in other 
episodes. In our study the time taken to remission was further classified 
into Short ( less than mean value i.e less than 92 days), medium (Mean to 
Mean + 1SD, i.e 93 to 132 days) and long ( greater than mean +1 SD, i.e 
> 132 days) for further analysis.  
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Table 5.58: Factors affecting time to remission 
Variables Mean SD P-value 
Gender Male 102.51 48.23 0.093 
Female  81.56 27.66 
Age category  
14-30 
85.44 24.63 0.363 
31-50 88.2 34.07 
51-80 109.67 47.56 
Occupational 
status 
Un-employed 93 35.04 0.066 
House wife 70 25.93 
Unskilled 81.74 29.86 
Semi skilled 96.83 28.44 
Skilled 102 34.96 
Socio-economic 
status 
Low 92 32.96 0.262 
Middle 86 33.01 
High 105 26.57 
Family type Nuclear 94 43.57 0.126 
Extended 
Nuclear/ Joint 
79 26.19 
Family History Present 95.0 41.64 0.047 
Absent 79.12 32.15 
Alcohol used 
disorder 
Present 103.91 56.97 0.103 
Absent 87.21 31.22 
Episode type Euphoric 88.83 32.67 0.853 
Dysphoric 89.46 32.48 
Mixed 88.00 20.24 
Psychotic 
symptoms 
Present 92.44 32.92 0.509 
Absent 85.91 30.39 
Irritability 
aggression  
Present 94.6 31.58 0.541 
Absent 81.40 30.34 
Precipitating 
stressors  
Present 91.55 29.39 0.178 
Absent 86.91 33.47 
Age at on set 14-30 88.66 28.67 0.958 
31-60 87.17 9.30 
Duration of 
illness 
<5 Years 86.58 28.02 0.684 
5-15 years 90.15 39.01 
>15 Years 102.30 40.8 
Episode Number 1 84.13 58.77 0.172 
2 77.50 16.98 
3 97.73 30.32 
4 105.38 27.47 
5 97 42.85 
>5 (Multiple) 111 15.20 
Type of previous 
episode  
Manic  84.14 26.40 0.125 
Depressive 106.21 30.73 
Mixed 97.0 27.63 
p value is significant at the 0.05 level  
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4.9% of patients with no alcohol use in current episode had longer 
time to remission, whereas 30.1% of those in alcohol use group showed 
longer time to remission (p=0.07). When the previous episode was manic, 
3.5% showed long and 32.1% showed medium time to remission, 
whereas when the previous episode was depression, 21% took long time 
and 46% took medium time to remission 
FUNCTIONING AT 6 MONTHS POST REMISSION: 
The mean SOFAS score at 6 months was 74.37 with a standard 
deviation 14.45. The median SOFAS score was 80. ( IQR 70-85). The 
episode wise SOFAS score post 6 months remission is 79 and 80 in first 
and second episodes respectively, 72 and 73 in the third and fourth 
episodes, 60 in the 5th episode and 65 collectively in the multiple episode 
group.  
Figure 3: Relationship of number of episodes to functioning at 6 months. 
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SOFAS score of 70-100 is defined as good functioning, 50-69 is 
defined as borderline functioning and 0-39 as impaired functioning. 
The SOFAS score was significantly affected by age, duration of 
illness, number of previous episodes, Time taken for remission in current 
episode, family history of mental illness, alcohol use. 
The mean age of the patients with good functioning was 30 years 
and in those with borderline functioning the mean age is 45 years. (p= 
0.001). The average duration of illness assosciated with good functioning 
is 51.46 months, whereas a mean duration of 171.55 months is 
assosciated with borderline functioning at 6 months post remission. The 
mean time taken for remission of current episode was 83 days in the good 
functioning group and 118 days in the borderline functioning group. 
A family history of mental illness resulted in SOFAS score of 
73.08 while patients with no family history had an average SOFAS score 
of 79.41 (p= 0.02). 
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Table 5.59 : Factors affecting Functioning at 6months post remission  
Variable Mean SD  
Gender Male 72.65 16.21 0.169 
Female  75.33 11.57 
Age category 14-30 77.98 9.12 0.00 
31-50 74 11.9 
51-80 54.44 22.97 
Occupational 
status 
Un-employed 73 14.81 0.393 
House wife 84 8.3 
Unskilled 74 15.07 
Semi skilled 71 16.46 
Skilled 74 9.27 
Socio-economic 
status 
Low 75 11.97 0.926 
Middle 74 15.9 
High 73 11.45 
Family type Nuclear 73.18 17.82 0.513 
Extended 
Nuclear/ Joint 
76.41 11.30 
Family History Present 72.65 14.84  
0.016 Absent 79.41 8.26 
Alcohol used 
disorder 
Present 70.95 20.22 0.003 
Absent 75.15 10.91 
Episode type Euphoric 73.10 15.12 0.484 
Dysphoric 75.94 11.37 
Mixed 71.00 19.83 
Psychotic 
symptoms 
Present 73.95 15.56 0.602 
Absent 74.11 12.67 
Irritability 
aggression  
Present 73.90 14.39 0.928 
Absent 74.21 13.63 
Precipitating 
stressors  
Present 74.58 15.8 0.570 
Absent 73.58 12.4 
Age at on set 14-30 74.28 13.05  
0.253 31-60 74.50 16.65 
Duration of 
illness 
<5 Years 77.22 10.89  
0.00 5-15 years 74.77 6.82 
>15 Years 54 20.65 
Episode 
Number 
1 79.39 10.12 0.001 
2 8045 10.5 
3 70.0 17.66 
4 72.50 5.97 
5 60.00 14.14 
>5 (Multiple) 64.62 15.20 
p value is significant at the 0.05 level  
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DISCUSSION 
The mean age of onse of illness of the sample is 26.9 years and 
median was 24 years. This is comparable to the age at onset in Indian 
studies by Ram et al ., 26.74 (11.03) years, and Mohit P chopra et al 
2006., 27.7 (SD 9.1 years) and higher than that in western population 
where the mean age is 22.9years (SD 10 years). 
The sex distribution in our sample was 51% of females and 49% of 
males which closely reflects the fact that Bipolar I disorder occurs with 
equal frequency in both men and women. 
A family history of mood disorder was present in 9.5% of the 
sample and psychotic illness was present in 4.7% , which is high 
compared to the IOWA studies showing 5.35% incidence in relatives. 
This difference is probably due to the inclusion of two generations while 
obtaining family history. Our study correlates with the observation of 
Singal59 et al 1986, who found a 40% incidence of psychiatric illness in 
families of the experimental population. 
45.25% of the patients had a precipitating stressor. A study By 
Singal59et al 1984 showed, 63% occurrence of stressful life events 
preceding manic episodes. Our study results were also consistent with the 
results of Dunner et al. (1979), Ambelas (1979) and Leff (1976)  
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Seasonality was present in 4% of our sample population , which 
was consistent with Kasper et al, 1989 who reports a 4.3% prevalence of 
Seasonal affective disorder. We found a significant male predominance of 
seasonality, comparable to Raj kumar 61et al 2015. 
The period of symptoms before contact with mental health services 
was 48.37 (SD 70.1) days in male and 23.42 (SD 37.68) days in females 
(p=0.028) . This could be explained by the culturally sanctioned levels of 
activity for males and prior diagnoses of alcohol or substance misuse 
disorders were associated with substantially longer median delays to 
diagnosis (Rashmi patel et al 2015).  
 The period of symptoms before contact with MHS also increased 
with increasing age (21 days for patints in 14-30 years age group, 40 days 
in 31-50 year age group and 97 days in 51-80 year age group). This is due 
to the family control over the younger population, and the high risk acts 
which the younger age group are involved in. Also older age group 
patients already have several episodes and at a lower level of functioning, 
which leads to unhealthy family support. The duration of symptoms 
before contacting MHS is also higher when the episode is precipitated by 
a stressor ( 44 days in episode with stressors and 28 days in episodes with 
no stressors, p= 0.050), probably as the symptoms are taken as part of 
maladaptive coping or venting out . The presence of irritability and 
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aggression resulted in a delay in contact with mental health services 
(mean of 23.1 days when there was no irritability and aggression and 
44.96 days when there was irritability and aggression (p= 0.004), 
probably due to the time taken by the family , to mobilize support, for 
bringing in the patient by coercion. Consequently there is a higher YMRS 
scores for such patients at first contact with Mental health services (23.39 
in those with out aggression and 27.75 in those with aggression , 
p= 0.017). 
 The intercycle length was shorter when the previous episode is 
depression (16.36 months  (SD 25.63)) and higher when the previous 
episode is mania ( 27.18months (SD 29.46)).The difference is statistically 
significant (p=0.00) 
 The unipolarity of mania was maintained in 25.8 % of the sample 
population upto the study enrollment. (7.1% of the sample upto the 3rd 
episode, 1.1% upto 4th episode, 2.3% upto 5th episode and 1.1% in the 15th 
episode). 
 Psychotic symptoms in the current episode were more prevalent 
when there is a family history of psychiatric illness (44% when there is 
family history Vs 30% when there is no significant family history, 
p=0.044) 
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 Also, when there was a positive family history, there was a better 
compliance to medication. 
  The mean time taken for remission from a mood episode 91.79 
days (SD 40.2 days), The results were consistent with Karan Kora et al., 
80.9 (SD 73.8) and Tohen et al 2003., 13.7 weeks ( SD 21.8). It was also 
on par with results from Indian studies by Mohit.P. Chopra (2006)., 13 
(SD 15.4) weeks. It was higher than the values by Leelahanaj et al 2013., 
showing median time to remission at 58 days (95% CI 54.9- 84.2), 
probably due to the inclusion of more higher number of episodes.  
Female sex was assosciated with a shorter time to remission , in all the 
episodes but the difference is statistically significant only in the first 
episode (106 days Vs 58 days )which was consistent with Tohen et al 
2003., but not with that of Geller et al (2004).  In the other episodes no 
statistically significant difference in the time for remission is found 
between genders. Patients with later age of onset had longer time to 
remission. The time taken for remission also longer with the higher 
number of previous episodes. Higher number of patients with alcohol use 
in the current episode showed longer time to remission compared to non 
users (p=0.007) 
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  In our study, no difference was noted between the initial YMRS 
scores, duration of hospitalization, or presence or absence of psychotic 
symptoms on the time taken for remission.  
 The mean SOFAS score at 6 months was 74.37 with a standard 
deviation 14.45. The episode wise SOFAS score post 6 months remission 
is 79 and 80 in first and second episodes respectively, 72 and 73 in the 
third and fourth episodes, 60 in the 5th episode and 65 collectively in the 
multiple episode group. 
20.2% were having borderline or impaired functioning as 
evidenced by SOFAS score of less than 70, while the rest of the sample 
achieved an average score of 80, which means no more than a slight 
impairment in social occupational or school functioning. This was higher 
than studies by Tohen et al., and MS Wesley 2018. Our study correlates 
with Chaterjee et al60 1989 reports that 42.5 % were functional at 90 days  
(3 months ) following a manic episode, whereas 27.5 % were not 
functional though asymptomatic at the end of 3 months. 
This may be due to higher number of female sex in the sample, the 
family support system which is healthy in higher number of sample 
population, and even patients treated on OP basis with milder form of 
manic episodes were included in the study. Our study results are also 
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consistent with Gin et al who reports only modest impairment in 
executive functioning. 
 The SOFAS score was affected by age, gender, duration of illness, 
number of previous episodes,family history of mental illness, alcohol use 
disorder before the onset of the episode. 
The SOFAS score was better for females at 6 months post remission75.33 
(11.57), compared to males 72.65 (SD 16.21), p=0.016. The SOFAS 
score at 6 months was 72.65 (SD 14.84) when there was a history of 
mental illness in the family, and 79.41 (SD 8.26) in the absence of mental 
illness (p=0.016). When there is comorbid diagnosis of Alcohol use 
disorder the mean SOFAS score was 70.95 (SD 10.9) and when there is 
no alcohol use disorder, SOFAs score was 75.15 (SD 10.91) (p=0.003). 
 The SOFAS score was not affected by family support, intercycle 
length, psychotic symptoms or duration of hospitalization as reported by 
Wesley et al and Tohen et al. 
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CONCLUSIONS 
 The mean age at onset of the illness was 26.9 years.  
 The mean number of previous episodes in the sample population 
was 3.02.  
 The mean number of episodes in males were 3.59 and  
females 2.49.  
 Mean YMRS score of the sample population was 25.65. 
 Seasonality was present in 4.8% of the study population.  
 Co morbid medical illness is present in 20.2% of the sample.  
 The mean hospitalization was 8 (SD 9) days .  
 The follow up was regular in 67.9% of the patients.  
 78.6% were compliant to medications.  
 The intercycle interval is 18.63 months. 
 The period of symptoms before contact with mental health services 
was shorter for females.  
 The period of symptoms before contact with MHS is shorter for 
younger age group. 
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 The duration of symptoms before contacting MHS is also higher 
when the episode is precipitated by a stressor.  
 The presence of irritability and aggression resulted in a delay in 
contact with mental health services.  
 Higher YMRS scores at first contact with Mental health services is 
seen in patients with irritability and aggression . 
 The intercycle length was shorter when the previous episode is 
depression.  
 A positive family history of mental illness predicted the presence 
of psychotic symptoms in the current episode. 
 The mean time taken for remission was 91.79 days ( SD 40.2 
days).  
 The time taken for remission is significantly different among the 
males and females in the first episode,but not in other episodes.  
 The time taken for remission was influenced by the age at onset, 
number of previous episodes, alcohol use in current episode and 
type of previous episode. 
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 The patients with a later age of onset of the disease, greater number 
of previous epispodes, alcohol use in current episode and previous 
depressive episode showed a longer time to remission. 
 The mean SOFAS score at 6 months was 74.37 (SD 14.45).  
 The Occupational and social functioning (as assessed by SOFAS 
score) was significantly decreased with increasing age, longer 
duration of illness, greater number of previous episodes, longer 
time taken for remission in current episode, positive family history 
of mental illness, presence of alcohol use disorder independent of 
the episode.  
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LIMITATIONS AND RECOMMENDATIONS 
1. The study can be done in a larger sample. 
2. The followup period can be extended for 12 months and 24 months 
post remission. 
3.  Cognitive assessment in the interepisodic period can be done. 
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Questionnaire 
SOCIO DEMOGRAPHIC PROFILE:  
1. ID NO. 
2.  Age 
3. Sex                          1.male 2.female 
4. Education                1.Uneducated 2. Primary Education 3.Secondary 
school education 
5. Occupation              1.unskilled  2. Semiskilled   3.skilled 
6. Occupational status 1. Occupied 2. Unoccupied 
7. Socioeconomic status  
                                     1. Upper 2. Middle  3.Lower 
8. Marital Status           1.married  2.single              
9. FAMILY TYPE         1.Nuclear  2.Joint  
10. Family support        1. healthy  2..unhealthy 
HISTORY 
11.Diagnosed Childhood disorders 
      a) Present b) absent 
12. Premorbid Personality 
      a)Extrovert b) Ambivert c)Introvert 
      a) Open to new experiences b) conservative  
13.Family History of mental illness 
  a.Affective disorder   b.Schizophrenia spectrum disorders c.Others  
14.Alcohol use                                 1.Yes             2. No 
15. Alcohol use in current episode  1. Yes             2. No 
16. Cannabis use                              1.Yes             2.No 
17. Other substance use 
                                                          1.Yes             2.No  
 
CHARACTERISTICS OF CURRENT EPISODE 
18.Euphoric/Dysphoric/ Mixed 
19.Psychotic Symptoms                 a) Present     b) absent 
20.Irritability and aggression         a)Present  b) absent 
21.Stressors in the current episode a)Present  b) absent 
22.Period of symptoms before hospitalization  
ILLNESS CHARACTERISTICS AGE AT ONSET: 
23.Duration of illness: 
24.Number of  preceding episodes: 
Manic: 
Depressive: 
25.Previous episode       a) manic b)depressive c)mixed 
26.Mean interepisodic interval 
27.Seasonality 
          28.Co-morbid medical illness  
          29.Concomitant medications used 
          30.No. of drugs used in maintenance phase 
          31.The drug used in maintenance phase 
a.Sodium Valproate  
b.Lithium 
c.Antipsychotics-1. Risperidone  
                                    2.Haloperidol 
                                    3.Others 
32. Followup 1.Regular  2. delayed by 2 or 3 days  3. Irregular 
33. Compliance 1. Compliant  2. Non compliant 
INFORMED CONSENT FORM 
STUDY: “COHORT  STUDY OF THE CHARACTERISTICS, 
COURSE AND OUTCOME OF MANIC EPISODES  ” 
STUDY CENTRE: Department of Psychiatry , Govt. Kilpauk Medical 
College Hospital. 
PATIENT’S NAME : 
PATIENT’S AGE     :     
I.P NO.          : 
Patient  may check ( ) these boxes 
I confirm that I understood the purpose of the procedure for the above study.
        ( ) 
I had the opportunity to ask question and all my questions and doubts have 
been answered to my complete satisfaction. ( ) 
I understand that my participation in the study is voluntary and that I am 
free to withdraw at any time without giving reason, without my legal rights 
being affected.                    ( ) 
I understand that the ethical committee members  and the regulatory 
authorities will not need my permission to look at my health records, both in 
respect of the current study and any further research that may be conducted 
in relation to it, even if I withdraw from the study I agree to this access. 
                                     ( ) 
However, I understand that my identity will not be revealed in any 
information released to third parties or published, unless as required under 
the law.       ( ) 
I agree not to restrict the use of any data or results that arise from the study.
        ( ) 
I agree to take part in the above study and to comply with the instructions 
given during the study and faithfully co-operate with the study team and to 
immediately inform the study staff if I suffer from any deterioration in my 
health or well being or any unexpected or unusual symptoms.                                             
( ) 
I hereby consent to participate in this study.         ( ) 
I hereby give permission to undergo complete clinical examination and 
diagnostic tests including hematological, biochemical, radiological tests. 
                       ( ) 
Signature / thumb impression of Patient: 
Patient’s name and address: 
 
Place: 
Date: 
 
Signature of the investigator: 
Study investigator’s name: 
Place: 
Date: 
PARTICIPANTS' INFORMATION SHEET 
 
Investigator   : Dr. D.M. Arasi 
Name of the participant :  
 
Study title: 
COHORT  STUDY OF THE CHARACTERISTICS, COURSE AND 
OUTCOME OF MANIC EPISODES   
You are invited to take part in this research study. We have got approval 
from the IEC. You are asked to participate because you satisfy the eligibility 
criteria. 
What is the purpose of this research? 
 In this study, we aim to study the Characteristics  time taken for 
symptoms to settle down in a manic episode. We also try to analyse the 
factors which are associated with speedy recovery and slow recovery. The 
factors analysed are the socio demographic profile, the premorbid 
personality, the intelligence quotient, family history of BPAD , the number 
of episodes and the previous treatment status. 
Benefits: 
 This study will help to understand the factors accelerating the 
symptom resolution in patients suffering from this illness and hence will be 
of great help in the treatment of such patients in the future. 
Discomforts and risks: 
 No interventional procedure is done in this study. 
Confidentiality: 
 Patients who participate in the study and their details will be 
maintained confidentially and at any cost, those details will not be let out. 
 
Right to withdraw: 
Patients  will not be forced to complete the study. At any cost, in such 
circumstances the treatment  will not be compromised. 
 
 
Signature/Thumb impression of  the participant: 
 
 
Signature of the investigator: 
 
Date : 
Place : 
சுய ஒப்புதல் படிவம் 
ஆய்வு ெசய்யப்படும் தைலப்பு: 
" மன எழுச்சி ேநாயின் பண்பியல்பு, ேபாக்கு மற்றும் விைளவுகள் 
குறித்த ஆய்வு.” 
ஆராய்ச்சி நிைலயம்: மன ேநாயியல் துைறப் பிrவு, கீழ்ப்பாக்கம் 
மருத்துவக்கல்லூr அரசு மருத்துவமைன, ெசன்ைன. 
     பங்கு ெபறுபவrன் ெபயர்: 
பங்கு ெபறுபவrன் எண்: 
பங்கு ெபறுபவர் இதைன ( ) குறிக்கவும் 
ேமேல குறிப்பிட்டுள்ள மருத்துவ ஆய்வின் விவரங்கள் எனக்கு 
விளக்கப்பட்டது. என்னுைடய சந்ேதகங்கைளக் ேகட்கவும், அதற்கான 
தகுந்த விளக்கங்கைளப் ெபறவும் வாய்ப்பளிக்கப்பட்டது. ( ) 
நான் இவ்வாய்வில் தன்னிச்ைசயாகத்தான் பங்ேகற்கிேறன். எந்தக் 
காரணத்தினாேலா எந்தக் கட்டத்திலும் எந்த சட்ட சிக்கலுக்கும் 
உட்படாமல் நான் இவ்வாய்வில் இருந்து விலகிக் ெகாள்ளலாம் 
என்றும் அறிந்து ெகாண்ேடன்.      
  ( ) 
இந்த ஆய்வு சம்மந்தமாகவும், ேமலும் இது சார்ந்த ஆய்வு 
ேமற்ெகாள்ளும்ேபாதும், இந்த ஆய்வில் பங்குெபறும் மருத்துவர் 
என்னுைடய மருத்துவ அறிக்ைககைளப் பார்ப்பதற்கு என் அனுமதி 
ேதைவயில்ைல என அறிந்துெகாள்கிேறன். நான் ஆய்வில் இருந்து 
விலகிக் ெகாண்டாலும் இது ெபாருந்தும் என அறிகிேறன்.  (
 ) 
இந்த ஆய்வின் மூலம் கிைடக்கும் தகவல்கைளயும், பrேசாதைன 
முடிவுகைளயும் மற்றும் சிகிச்ைச ெதாடர்பான தகவல்கைளயும் 
மருத்துவர் ேமற்ெகாள்ளும் ஆய்வில் பயன்படுத்திக் ெகாள்ளவும், 
அைதப் பிரசுrக்கவும் என் முழு மனதுடன் சம்மதிக்கிேறன்.  
 ( ) 
இந்த ஆய்வில் பங்கு ெகாள்ள ஒப்புக்ெகாள்கிேறன். எனக்குக் 
ெகாடுக்கப்பட்ட அறிவுைரகளின் படி நடந்துெகாள்வதுடன், இந்த 
ஆய்ைவ ேமற்ெகாள்ளும் மருத்துவ அணிக்கு உண்ைமயுடன் 
இருப்ேபன் என்றும் உறுதியளிக்கிேறன். என் உடல் நலம் 
பாதிக்கப்பட்டாேலா அல்லது எதிர்பாராத வழக்கத்திற்கு மாறாக 
ேநாய்க்குறி ெதன்பட்டாேலா உடேன அைத மருத்துவ அணியிடம் 
ெதrவிப்ேபன் என உறுதி அளிக்கிேறன்.     
        ( ) 
இந்த ஆய்வில் எனக்கு மருத்துவப் பrேசாதைன ெசய்து ெகாள்ள 
மற்றும் ஆய்வில் பங்ேகற்க நான் முழு மனதுடன் சம்மதிக்கிேறன்.
           
  ( ) 
பங்ேகற்பவrன் ைகெயாப்பம் / கட்ைடவிரல் ேரைக:  
 
___________________ 
இடம்: ____________________________ 
ேததி: _____________________________ 
பங்ேகற்பவrன் ெபயர் மற்றும் விலாசம்:: 
 
ஆய்வாளrன் ைகெயாப்பம் _________________________ 
இடம் _________________________ 
ேததி __________________________ 
ஆய்வாளrன் ெபயர் ____________________________
ஆராய்ச்சி தகவல் தாள் 
கீழ்ப்பாக்கம் மருத்துவக்கல்லூr அரசு மருத்துவமைன மன ேநாயியல் 
துைறப் பிrவில்  மன எழுச்சி ேநாயின் பண்பியல்பு, ேபாக்கு மற்றும் 
விைளவுகள் குறித்து ஆராய்ச்சி ெசய்ய உள்ேளாம்.  நீங்கள் இந்த 
ஆராய்ச்சியில் பங்ேகற்க நாங்கள் விரும்புகிேறாம். இந்த ஆராய்ச்சியில் 
பங்ேகற்பதால் தங்களது ேநாயின் ஆய்வறிக்ைகேயா அல்லது சிகிச்ைசேயா 
பாதிக்கப்படாது என்பைதயும் ெதrவித்துக் ெகாள்கிேறாம். 
இந்த ஆராய்ச்சியின் முடிவுகைள அல்லது கருத்துகைள ெவளியிடும் 
ேபாேதா அல்லது ஆராய்ச்சியின் ேபாேதா தங்களது ெபயைரேயா அல்லது 
அைடயாளங்கைளேயா ெவளியிடமாட்ேடாம் என்பைதயும் ெதrவித்துக் 
ெகாள்கிேறாம். 
இந்த ஆராய்ச்சியில் பங்ேகற்பது தங்களுைடய விருப்பத்தின் ேபrல் 
தான் இருக்கிறது. ேமலும் நீங்கள் எந்ேநரமும் இந்த ஆராய்ச்சியில் இருந்து 
பின்வாங்கலாம் என்பைதயும் ெதrவித்துக்ெகாள்கிேறாம். 
இந்த சிறப்புப் பrேசாதைனகளின் முடிவுகைள ஆராய்ச்சியின் ேபாேதா 
அல்லது ஆராய்ச்சியின் முடிவின் ேபாேதா தங்களுக்கு அறிவிப்ேபாம் 
என்பைதயும் ெதrவித்துக்ேகாள்கிேறாம்.  
 
ஆராய்ச்சியாளர் ைகெயாப்பம்   பங்ேகற்பாளர் ைகெயாப்பம் 
 
ேததி:                                     ேததி: 
 
 
 
 
 
 
 
 
 Young Mania Rating Scale (YMRS)  
 
  
1. Elevated Mood  
 Absent  
 Mildly or possibly increased on questioning  
 Definite subjective elevation; optimistic, self-confident; cheerful; appropriate to content  
 Elevated, inappropriate to content; humorous  
 Euphoric; inappropriate to content; singing  
 
2. Increased Motor Activity – Energy  
 Absent  
 Subjectively increased  
 Animated; gestures increased  
 Excessive energy; hyperactive at times; restless (can be calmed)  
 Motor excitement; continuous hyperactivity (cannot be calmed)  
 
3. Sexual Interest  
 Normal; not increased  
 Mildly or possibly increased  
 Definitive subjective increase on questioning  
 Spontaneous sexual content; elaborates on sexual matters; hypersexual by self-report  
 Overt sexual acts (towards patients, staff, or interviewer)  
 
4. Sleep  
 Reports no decrease in sleep  
 Sleeping less than normal amount by up to one hour  
 Sleeping less than normal by more than one hour  
 Reports decreased need for sleep  
 Denies need for sleep  
 
5. Irritability  
 Absent  
 2 Subjectively increased  
4 Irritable at times during interview; recent episodes of anger or annoyance on ward  
6 Frequently irritable during interview; short, curt throughout  
 8Hostile, uncooperative; interview impossible  
 
6. Speech (Rate and Amount)  
0 No increase  
2 Feels talkative  
4 Increased rate or amount at times, verbose at times  
6 Push; consistently increased rate and amount; difficult to interrupt  
8 Pressured; uninterruptible, continuous speech  
7. Language – Thought Disorder  
 Absent  
 Circumstantial; mild distractibility; quick thoughts  
 Distractible; loses goal of thought; changes topics frequently; racing thoughts  
 Flight of ideas; tangentiality; difficult to follow; rhyming; echolalia  
 Incoherent; communication impossible  
 
8. Content  
 1Normal  
 2 Questionable plans, new interests  
4 Special project(s); hyperreligious  
6 Grandiose or paranoid ideas; ideas of reference  
8 Delusions; hallucinations  
 
9. Disruptive – Aggressive Behavior  
 
0 Absent; cooperative  
2 Sarcastic; loud at times; guarded  
4 Demanding; threats on ward  
6 Threatens interviewer; shouting; interview difficult  
8 Assaultive; destructive; interview impossible  
 
10. Appearance  
 Appropriate dress and grooming  
 Minimally unkempt  
 Poorly groomed; moderately disheveled; overdressed  
 Disheveled; partly clothed; garish makeup  
 Completely unkempt; decorated; bizarre garb  
 
11. Insight  
 Present; admits illness; agrees with need for treatment  
 Possibly ill  
 Admits behavior change, but denies illness  
 Admits possible change in behavior, but denies illness  
 Denies any behavior changes  
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2 24 1 4 3 2 1 2 1 1 2 2 0 0 1 1 1 2 2 2 1 2 7 44 24 0.23 0 0 0 0 0 n 0 0 ir nc 73 85
3 28 2 3 0 2 2 2 1 1 2 1 0 0 1 1 1 1 2 2 2 1 20 22 28 0.66 0 0 0 0 0 n 0 0 r c 42 90
4 18 2 3 4 2 1 1 1 1 2 1 0 0 1 1 1 1 2 2 1 2 8 32 18 0.33 0 0 0 0 0 n 0 0 ir nc 57 90
5 27 1 4 3 2 2 1 1 1 2 1 1 1 2 1 2 1 2 1 2 1 30 36 27 1 0 0 0 0 0 n 0 0 r c 84 88
6 28 2 3 2 2 2 1 2 1 1 1 4 5 1 1 1 1 1 1 2 2 6 26 28 0.2 0 0 0 0 0 n 0 0 ir c 70 65
7 30 1 2 2 2 1 1 1 1 3 2 1 5 2 1 1 1 1 1 1 2 20 37 30 0.66 0 0 0 0 0 n 0 0 ir nc 123 85
8 32 1 3 2 1 1 2 2 1 2 2 1 5 2 2 1 1 2 1 1 2 20 27 32 0.6 0 0 0 0 0 n 0 0 r c 64 85
9 26 2 3 1 2 2 1 1 1 1 2 1 5 1 1 1 1 2 1 1 2 30 28 26 1 0 0 0 0 0 n 0 0 r c 42 73
10 31 2 3 1 2 2 1 1 1 1 1 1 5 1 1 1 1 1 1 2 2 3 26 31 0.1 0 0 0 0 0 n 0 0 r c 42 86
11 24 2 3 1 3 1 1 2 1 2 2 1 5 1 1 1 1 2 1 1 1 12 32 22 24 1 1 0 1 24 n 0 0 ir c 83 86
12 23 2 2 0 2 2 2 1 1 2 1 1 5 1 1 1 1 2 1 2 2 12 24 23 0.4 0 0 0 0 0 n 0 0 r c 78 86
13 14 2 3 4 2 1 2 1 1 2 2 2 2 1 1 1 1 1 1 2 2 15 20 14 0.5 0 0 0 0 0 n 0 0 r c 49 70
14 28 2 3 4 1 1 1 1 1 1 2 2 3 1 1 1 1 2 1 2 2 35 28 28 1.1 6 0 0 0 6 n 0 0 ir c 70 80
15 30 1 4 3 2 2 1 1 1 2 2 1 1 2 2 1 2 1 2 2 2 60 16 30 2 0 0 0 0 0 n 0 0 r c 45 80
16 26 1 3 2 3 2 1 1 1 2 1 2 4 2 2 1 1 1 2 2 2 10 24 26 0.33 0 0 0 0 0 n 0 0 ir nc 320
17 38 1 3 2 2 1 1 2 1 2 1 1 5 1 2 1 1 2 2 1 1 240 30 38 8 0 0 0 0 0 n 0 0 r c 120 75
18 17 1 2 1 3 2 1 1 1 2 2 6 2 2 2 1 1 1 2 1 1 120 30 17 4 0 0 0 0 0 n 0 0 r c 75 80
19 26 1 2 1 2 2 2 2 1 2 1 4 5 1 1 1 2 2 2 1 2 14 23 26 0.45 0 0 0 0 0 n 0 0 ir nc 70 80
20 30 2 1 1 2 1 1 2 1 2 2 1 5 1 1 1 1 1 2 1 2 30 26 30 1 0 0 0 0 0 n 0 0 ir nc 73 78
21 36 2 2 1 1 2 1 2 1 3 2 1 5 1 1 1 1 1 2 2 1 7 38 36 0.25 0 0 0 0 0 n 0 0 ir c 72 85
22 45 1 2 4 2 2 1 2 1 1 1 2 4 1 2 1 1 1 2 1 2 90 48 45 3 0 0 0 0 0 n 3 0 r c 136 60
23 55 1 3 1 1 2 1 2 1 3 2 0 0 1 1 1 2 1 2 2 2 45 16 45 120 0 0 0 0 0 n 2 0 r nc 35 80
24 30 2 4 0 2 2 2 1 1 3 2 6 5 1 1 1 1 2 1 1 1 60 24 30 2 0 0 0 0 0 n 0 0 r c 44 90
25 54 1 3 2 2 2 1 2 1 2 1 1 5 1 2 1 1 1 2 1 1 180 26 54 6 0 0 0 0 0 n 0 0 r nc 147 50
26 32 1 3 1 1 2 1 1 1 1 1 0 0 2 1 1 2 1 1 2 1 75 24 31 18 1 1 0 1 18 n 0 0 r c 90 90
27 25 1 4 3 2 1 1 2 1 3 2 0 0 1 1 1 2 1 2 2 2 7 22 24 12 2 1 1 1 6 n 0 2 r nc 103 75
28 16 2 2 -1 1 1 1 1 1 2 2 0 0 1 1 1 1 3 2 2 2 12 22 16 0.4 0 0 0 0 0 n 0 0 r nc 70 80
29 23 1 2 2 1 1 1 1 1 1 1 7 5 2 1 1 1 2 1 2 1 30 26 21 24 2 1 1 1 15 n 0 0 r c 115 78
30 45 2 3 1 3 1 1 1 1 2 1 1 5 1 1 1 1 1 1 2 1 14 26 43 24 1 1 0 1 24 n 0 0 ir nc 48 80
31 18 2 2 4 1 2 2 2 2 2 2 5 5 1 1 1 1 1 1 1 2 60 20 19 24 1 1 0 1 12 n 0 0 r nc 90 86
32 21 2 3 4 1 2 2 1 1 3 2 6 5 1 1 1 1 1 1 2 2 30 26 18 24 2 1 1 1 10 n 0 1 ir c 98 70
33 27 1 4 3 2 1 2 1 1 1 1 1 5 2 1 1 2 1 2 2 1 21 35 25 24 1 1 0 1 24 n 0 0 ir c 95 75
34 23 1 2 2 3 2 1 2 1 2 1 7 1 1 1 1 1 2 2 1 2 30 26 22 18 1 1 0 1 18 n 2 0 ir c 91 80
35 30 2 2 2 3 1 1 1 1 1 1 1 5 1 2 1 1 1 2 2 2 7 19 26 48 3 2 1 1 6 n 0 1 r c 105 65
36 27 2 2 1 3 1 2 1 1 2 2 1 5 1 1 1 1 3 2 1 1 30 15 25 24 1 1 0 1 24 n 0 0 ir c 82 82
MASTER CHART
37 48 2 3 1 3 2 2 2 1 2 2 5 5 1 1 1 2 2 2 2 1 20 18 47 12 1 1 0 1 12 n 0 1 ir c 79 75
38 42 2 2 1 3 3 1 1 1 2 2 1 5 1 1 1 1 2 2 1 1 4 22 38 48 4 4 0 1 12 n 0 1 r c 64 40
39 28 2 4 0 2 2 1 1 1 2 2 2 1 1 1 1 1 1 2 1 1 2 18 26 24 1 1 0 1 24 n 0 0 r c 62 90
40 24 2 2 0 2 1 1 1 1 1 1 7 3 1 1 1 1 1 2 1 1 15 43 19 60 2 2 0 1 24 n 0 0 r c 94 75
41 40 1 4 3 3 2 2 1 1 2 2 0 0 1 1 1 1 1 2 1 2 36 18 28 144 7 4 3 2 18 n 0 3 r c 74 70
42 47 1 3 2 2 2 1 1 1 1 1 5 5 2 2 1 1 1 1 2 1 7 19 37 120 2 2 0 1 24 p 0 0 r c 90 85
43 32 2 3 1 2 1 1 1 1 2 1 7 3 1 1 1 1 3 1 1 2 240 29 18 168 1 1 0 1 144 n 0 0 r c 78 80
44 28 2 3 1 1 1 1 2 1 2 1 6 5 1 1 1 1 1 1 2 2 20 18 16 144 2 2 0 1 24 n 0 1 r c 50 80
45 34 2 3 1 1 2 1 1 1 2 1 1 5 1 1 1 2 1 1 1 2 15 32 28 72 3 2 1 2 24 n 0 3 ir c 124 75
46 25 2 3 0 3 1 2 1 1 1 1 3 3 1 1 1 1 2 1 1 2 7 46 15 120 2 2 0 1 0 n 0 1 ir c 105 72
47 38 1 3 2 3 1 1 1 1 3 2 1 5 2 2 1 1 2 2 1 2 30 29 30 96 1 1 0 1 96 n 1 0 r c 56 80
48 29 1 3 2 2 1 1 1 1 3 2 4 5 1 2 1 1 3 2 1 1 7 27 22 84 2 2 0 1 36 n 3 2 r c 101 70
49 35 1 3 2 1 3 1 2 1 2 1 5 5 2 2 1 2 2 2 1 2 7 18 24 144 4 4 0 1 4 n 0 0 r c 56 70
50 42 1 1 4 1 2 1 2 1 3 2 0 0 1 1 2 2 2 1 1 2 20 34 25 204 2 2 0 1 24 n 0 1 ir nc 168 60
51 41 2 3 0 2 2 2 1 1 1 2 0 0 1 1 1 2 2 2 2 2 10 18 25 192 3 3 0 1 48 n 0 2 r c 42 70
52 55 1 4 2 2 2 1 1 1 2 2 6 5 2 1 1 1 1 1 1 1 365 23 20 420 2 1 1 2 144 n 1 3 r c 58 10
53 50 1 3 2 2 2 2 1 1 2 1 1 5 2 2 1 1 2 1 2 2 15 26 25 280 15 15 0 1 12 p 0 2 r c 79 50
54 58 1 4 1 1 2 2 1 1 2 1 1 5 2 2 2 1 1 1 1 1 60 20 23 280 15 10 5 2 12 n 1,2 1 r c 140 50
55 39 2 2 2 3 1 1 1 1 2 2 7 1 1 1 1 1 1 2 1 1 30 18 19 240 6 4 2 1 36 n 1,3 3 r c 106 60
56 29 2 2 0 1 2 2 1 1 1 1 0 0 1 1 1 1 2 1 1 1 10 20 27 24 2 1 1 2 12 n 3 1 ir c 108 70
57 15 1 3 2 2 1 1 2 1 3 2 0 0 1 1 1 1 1 2 1 1 5 14 14 14 1 0 1 2 12 n 0 0 r c 55 80
58 35 1 2 2 1 2 1 1 1 3 2 0 0 1 1 1 2 1 2 2 1 40 22 33 24 1 0 1 2 24 p n 0 r c 65 80
59 18 1 3 4 2 2 1 1 1 2 2 0 0 2 2 1 1 2 2 1 2 4 18 17 12 1 0 1 2 6 n 0 0 r c 76 85
60 34 2 4 4 2 3 1 1 1 2 2 0 0 1 1 1 1 1 2 1 1 4 36 29 60 6 1 1 2 12 n 0 0 r nc 106 80
61 26 2 4 3 1 2 1 1 1 1 1 4 5 1 1 1 1 2 1 2 1 4 14 21 60 3 1 2 2 6 n hypot 1 r c 120 70
62 32 2 4 3 2 2 1 1 1 2 2 1 5 1 1 1 1 2 1 1 2 7 18 28 48 5 3 2 2 12 n 0 1 r c 140 65
63 21 1 3 2 3 2 1 1 1 1 2 7 3 2 2 1 1 1 1 1 2 30 37 20 12 1 0 1 2 12 n 0 0 r c 103 80
64 22 1 3 2 1 3 1 2 1 1 1 2 3 1 1 2 1 1 1 2 2 7 28 22 6 1 0 1 2 6 n 0 0 ir c 98 80
65 32 1 3 2 2 2 1 2 1 2 1 4 5 1 1 1 1 2 1 1 2 14 28 28 48 2 1 1 2 12 n 0 1 r nc 118 80
66 17 2 3 1 3 2 1 2 1 2 1 1 5 1 1 1 1 1 1 1 2 20 41 15 24 3 2 1 2 8 n 0 1 r nc 118 75
67 46 1 2 1 1 2 2 2 1 3 2 1 2 2 2 1 2 1 1 1 1 90 22 46 36 3 2 1 2 6 n 2 2 r c 124 80
68 18 2 3 4 1 1 1 2 2 1 1 2 4 1 1 1 1 1 1 2 2 40 36 17 12 1 0 1 2 12 n 0 0 ir c 98 40
69 26 2 4 3 2 1 1 1 1 3 2 1 5 1 1 1 1 1 2 2 1 10 20 24 24 1 0 1 2 24 n 0 0 r c 73 85
70 20 1 3 2 2 1 1 1 2 2 1 3 2 2 2 2 2 1 2 1 1 30 32 18 24 2 1 1 2 12 n 0 0 ir c 118 80
71 26 2 3 2 2 2 1 2 2 2 1 5 5 1 1 1 1 2 2 2 2 2 18 22 48 3 2 1 2 12 n 0 1 ir c 115 65
72 32 1 3 1 3 2 1 1 1 2 2 1 5 2 2 1 1 2 2 1 1 45 22 27 60 4 2 2 2 12 n 0 1 r c 135 60
73 42 2 1 0 1 2 2 1 1 3 2 7 1 1 1 1 1 1 2 2 2 14 14 41 12 1 0 1 2 12 n 0 2 r c 48 90
74 34 2 3 0 2 2 1 1 1 2 1 1 1 1 1 1 2 2 2 1 1 6 32 30 48 3 1 2 2 6 n 4 1 r c 95 80
75 45 1 4 3 3 2 1 1 1 1 1 0 0 2 2 2 2 2 2 2 2 40 28 33 144 5 4 1 2 12 n 0 1 r nc 93 80
76 30 2 4 3 2 1 1 1 1 1 1 4 5 1 2 1 1 2 1 1 1 7 12 22 96 4 2 2 2 12 n 0 1 r c 133 70
77 51 1 3 3 2 2 1 1 1 2 1 1 5 2 2 1 1 1 2 2 2 4 20 36 180 9 5 4 2 0 n 0 0 ir c 177 60
78 70 1 4 2 3 2 1 1 1 2 2 3 5 1 1 1 2 2 1 1 1 7 18 40 360 30 15 15 2 6 n 3 3 r c 148 80
79 68 2 3 3 2 1 1 2 1 1 1 1 5 1 1 1 1 1 2 2 2 60 27 30 456 30 20 10 2 12 n 2,3 0 r c 114 60
80 22 1 4 2 1 1 1 1 2 2 2 7 1 1 1 1 1 3 2 2 2 10 18 18 48 5 3 2 3 6 n 0 2 r c 123 75
81 65 2 3 1 1 2 2 2 1 2 1 1 3 1 1 1 2 1 2 1 1 60 29 22 516 2 1 1 3 204 n 0 0 ir c 94 70
82 60 1 1 1 2 1 1 1 1 2 2 1 5 2 2 1 1 3 2 2 2 90 22 35 300 25 3 22 3 12 p 0 0 r c 74 30
83 34 2 3 0 2 2 1 1 1 1 1 1 3 1 1 1 1 1 1 1 1 6 24 30 48 2 1 1 1 12 n 4 1 r c 46 75
84 24 2 2 0 2 2 2 1 1 1 2 1 3 1 1 1 1 2 2 1 1 3 42 20 48 1 1 0 1 48 n 0 0 r c 80 85
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1 27 1 3 1 2 1 1 1 1 1 1 0 0 1 1 1 1 2 1 1 1 21 42 27 0.66 0 0 0 0 0 n 1 0 r c 88 85
2 24 1 4 3 2 1 2 1 1 2 2 0 0 1 1 1 2 2 2 1 2 7 44 24 0.23 0 0 0 0 0 n 0 0 ir nc 73 85
3 28 2 3 0 2 2 2 1 1 2 1 0 0 1 1 1 1 2 2 2 1 20 22 28 0.66 0 0 0 0 0 n 0 0 r c 42 90
4 18 2 3 4 2 1 1 1 1 2 1 0 0 1 1 1 1 2 2 1 2 8 32 18 0.33 0 0 0 0 0 n 0 0 ir nc 57 90
5 27 1 4 3 2 2 1 1 1 2 1 1 1 2 1 2 1 2 1 2 1 30 36 27 1 0 0 0 0 0 n 0 0 r c 84 88
6 28 2 3 2 2 2 1 2 1 1 1 4 5 1 1 1 1 1 1 2 2 6 26 28 0.2 0 0 0 0 0 n 0 0 ir c 70 65
7 30 1 2 2 2 1 1 1 1 3 2 1 5 2 1 1 1 1 1 1 2 20 37 30 0.66 0 0 0 0 0 n 0 0 ir nc 123 85
8 32 1 3 2 1 1 2 2 1 2 2 1 5 2 2 1 1 2 1 1 2 20 27 32 0.6 0 0 0 0 0 n 0 0 r c 64 85
9 26 2 3 1 2 2 1 1 1 1 2 1 5 1 1 1 1 2 1 1 2 30 28 26 1 0 0 0 0 0 n 0 0 r c 42 73
10 31 2 3 1 2 2 1 1 1 1 1 1 5 1 1 1 1 1 1 2 2 3 26 31 0.1 0 0 0 0 0 n 0 0 r c 42 86
11 24 2 3 1 3 1 1 2 1 2 2 1 5 1 1 1 1 2 1 1 1 12 32 22 24 1 1 0 1 24 n 0 0 ir c 83 86
12 23 2 2 0 2 2 2 1 1 2 1 1 5 1 1 1 1 2 1 2 2 12 24 23 0.4 0 0 0 0 0 n 0 0 r c 78 86
13 14 2 3 4 2 1 2 1 1 2 2 2 2 1 1 1 1 1 1 2 2 15 20 14 0.5 0 0 0 0 0 n 0 0 r c 49 70
14 28 2 3 4 1 1 1 1 1 1 2 2 3 1 1 1 1 2 1 2 2 35 28 28 1.1 6 0 0 0 6 n 0 0 ir c 70 80
15 30 1 4 3 2 2 1 1 1 2 2 1 1 2 2 1 2 1 2 2 2 60 16 30 2 0 0 0 0 0 n 0 0 r c 45 80
16 26 1 3 2 3 2 1 1 1 2 1 2 4 2 2 1 1 1 2 2 2 10 24 26 0.33 0 0 0 0 0 n 0 0 ir nc 320
17 38 1 3 2 2 1 1 2 1 2 1 1 5 1 2 1 1 2 2 1 1 240 30 38 8 0 0 0 0 0 n 0 0 r c 120 75
18 17 1 2 1 3 2 1 1 1 2 2 6 2 2 2 1 1 1 2 1 1 120 30 17 4 0 0 0 0 0 n 0 0 r c 75 80
19 26 1 2 1 2 2 2 2 1 2 1 4 5 1 1 1 2 2 2 1 2 14 23 26 0.45 0 0 0 0 0 n 0 0 ir nc 70 80
20 30 2 1 1 2 1 1 2 1 2 2 1 5 1 1 1 1 1 2 1 2 30 26 30 1 0 0 0 0 0 n 0 0 ir nc 73 78
21 36 2 2 1 1 2 1 2 1 3 2 1 5 1 1 1 1 1 2 2 1 7 38 36 0.25 0 0 0 0 0 n 0 0 ir c 72 85
22 45 1 2 4 2 2 1 2 1 1 1 2 4 1 2 1 1 1 2 1 2 90 48 45 3 0 0 0 0 0 n 3 0 r c 136 60
23 55 1 3 1 1 2 1 2 1 3 2 0 0 1 1 1 2 1 2 2 2 45 16 45 120 0 0 0 0 0 n 2 0 r nc 35 80
24 30 2 4 0 2 2 2 1 1 3 2 6 5 1 1 1 1 2 1 1 1 60 24 30 2 0 0 0 0 0 n 0 0 r c 44 90
25 54 1 3 2 2 2 1 2 1 2 1 1 5 1 2 1 1 1 2 1 1 180 26 54 6 0 0 0 0 0 n 0 0 r nc 147 50
26 32 1 3 1 1 2 1 1 1 1 1 0 0 2 1 1 2 1 1 2 1 75 24 31 18 1 1 0 1 18 n 0 0 r c 90 90
27 25 1 4 3 2 1 1 2 1 3 2 0 0 1 1 1 2 1 2 2 2 7 22 24 12 2 1 1 1 6 n 0 2 r nc 103 75
28 16 2 2 -1 1 1 1 1 1 2 2 0 0 1 1 1 1 3 2 2 2 12 22 16 0.4 0 0 0 0 0 n 0 0 r nc 70 80
29 23 1 2 2 1 1 1 1 1 1 1 7 5 2 1 1 1 2 1 2 1 30 26 21 24 2 1 1 1 15 n 0 0 r c 115 78
30 45 2 3 1 3 1 1 1 1 2 1 1 5 1 1 1 1 1 1 2 1 14 26 43 24 1 1 0 1 24 n 0 0 ir nc 48 80
31 18 2 2 4 1 2 2 2 2 2 2 5 5 1 1 1 1 1 1 1 2 60 20 19 24 1 1 0 1 12 n 0 0 r nc 90 86
32 21 2 3 4 1 2 2 1 1 3 2 6 5 1 1 1 1 1 1 2 2 30 26 18 24 2 1 1 1 10 n 0 1 ir c 98 70
33 27 1 4 3 2 1 2 1 1 1 1 1 5 2 1 1 2 1 2 2 1 21 35 25 24 1 1 0 1 24 n 0 0 ir c 95 75
34 23 1 2 2 3 2 1 2 1 2 1 7 1 1 1 1 1 2 2 1 2 30 26 22 18 1 1 0 1 18 n 2 0 ir c 91 80
35 30 2 2 2 3 1 1 1 1 1 1 1 5 1 2 1 1 1 2 2 2 7 19 26 48 3 2 1 1 6 n 0 1 r c 105 65
36 27 2 2 1 3 1 2 1 1 2 2 1 5 1 1 1 1 3 2 1 1 30 15 25 24 1 1 0 1 24 n 0 0 ir c 82 82
MASTER CHART
37 48 2 3 1 3 2 2 2 1 2 2 5 5 1 1 1 2 2 2 2 1 20 18 47 12 1 1 0 1 12 n 0 1 ir c 79 75
38 42 2 2 1 3 3 1 1 1 2 2 1 5 1 1 1 1 2 2 1 1 4 22 38 48 4 4 0 1 12 n 0 1 r c 64 40
39 28 2 4 0 2 2 1 1 1 2 2 2 1 1 1 1 1 1 2 1 1 2 18 26 24 1 1 0 1 24 n 0 0 r c 62 90
40 24 2 2 0 2 1 1 1 1 1 1 7 3 1 1 1 1 1 2 1 1 15 43 19 60 2 2 0 1 24 n 0 0 r c 94 75
41 40 1 4 3 3 2 2 1 1 2 2 0 0 1 1 1 1 1 2 1 2 36 18 28 144 7 4 3 2 18 n 0 3 r c 74 70
42 47 1 3 2 2 2 1 1 1 1 1 5 5 2 2 1 1 1 1 2 1 7 19 37 120 2 2 0 1 24 p 0 0 r c 90 85
43 32 2 3 1 2 1 1 1 1 2 1 7 3 1 1 1 1 3 1 1 2 240 29 18 168 1 1 0 1 144 n 0 0 r c 78 80
44 28 2 3 1 1 1 1 2 1 2 1 6 5 1 1 1 1 1 1 2 2 20 18 16 144 2 2 0 1 24 n 0 1 r c 50 80
45 34 2 3 1 1 2 1 1 1 2 1 1 5 1 1 1 2 1 1 1 2 15 32 28 72 3 2 1 2 24 n 0 3 ir c 124 75
46 25 2 3 0 3 1 2 1 1 1 1 3 3 1 1 1 1 2 1 1 2 7 46 15 120 2 2 0 1 0 n 0 1 ir c 105 72
47 38 1 3 2 3 1 1 1 1 3 2 1 5 2 2 1 1 2 2 1 2 30 29 30 96 1 1 0 1 96 n 1 0 r c 56 80
48 29 1 3 2 2 1 1 1 1 3 2 4 5 1 2 1 1 3 2 1 1 7 27 22 84 2 2 0 1 36 n 3 2 r c 101 70
49 35 1 3 2 1 3 1 2 1 2 1 5 5 2 2 1 2 2 2 1 2 7 18 24 144 4 4 0 1 4 n 0 0 r c 56 70
50 42 1 1 4 1 2 1 2 1 3 2 0 0 1 1 2 2 2 1 1 2 20 34 25 204 2 2 0 1 24 n 0 1 ir nc 168 60
51 41 2 3 0 2 2 2 1 1 1 2 0 0 1 1 1 2 2 2 2 2 10 18 25 192 3 3 0 1 48 n 0 2 r c 42 70
52 55 1 4 2 2 2 1 1 1 2 2 6 5 2 1 1 1 1 1 1 1 365 23 20 420 2 1 1 2 144 n 1 3 r c 58 10
53 50 1 3 2 2 2 2 1 1 2 1 1 5 2 2 1 1 2 1 2 2 15 26 25 280 15 15 0 1 12 p 0 2 r c 79 50
54 58 1 4 1 1 2 2 1 1 2 1 1 5 2 2 2 1 1 1 1 1 60 20 23 280 15 10 5 2 12 n 1,2 1 r c 140 50
55 39 2 2 2 3 1 1 1 1 2 2 7 1 1 1 1 1 1 2 1 1 30 18 19 240 6 4 2 1 36 n 1,3 3 r c 106 60
56 29 2 2 0 1 2 2 1 1 1 1 0 0 1 1 1 1 2 1 1 1 10 20 27 24 2 1 1 2 12 n 3 1 ir c 108 70
57 15 1 3 2 2 1 1 2 1 3 2 0 0 1 1 1 1 1 2 1 1 5 14 14 14 1 0 1 2 12 n 0 0 r c 55 80
58 35 1 2 2 1 2 1 1 1 3 2 0 0 1 1 1 2 1 2 2 1 40 22 33 24 1 0 1 2 24 p n 0 r c 65 80
59 18 1 3 4 2 2 1 1 1 2 2 0 0 2 2 1 1 2 2 1 2 4 18 17 12 1 0 1 2 6 n 0 0 r c 76 85
60 34 2 4 4 2 3 1 1 1 2 2 0 0 1 1 1 1 1 2 1 1 4 36 29 60 6 1 1 2 12 n 0 0 r nc 106 80
61 26 2 4 3 1 2 1 1 1 1 1 4 5 1 1 1 1 2 1 2 1 4 14 21 60 3 1 2 2 6 n hypot 1 r c 120 70
62 32 2 4 3 2 2 1 1 1 2 2 1 5 1 1 1 1 2 1 1 2 7 18 28 48 5 3 2 2 12 n 0 1 r c 140 65
63 21 1 3 2 3 2 1 1 1 1 2 7 3 2 2 1 1 1 1 1 2 30 37 20 12 1 0 1 2 12 n 0 0 r c 103 80
64 22 1 3 2 1 3 1 2 1 1 1 2 3 1 1 2 1 1 1 2 2 7 28 22 6 1 0 1 2 6 n 0 0 ir c 98 80
65 32 1 3 2 2 2 1 2 1 2 1 4 5 1 1 1 1 2 1 1 2 14 28 28 48 2 1 1 2 12 n 0 1 r nc 118 80
66 17 2 3 1 3 2 1 2 1 2 1 1 5 1 1 1 1 1 1 1 2 20 41 15 24 3 2 1 2 8 n 0 1 r nc 118 75
67 46 1 2 1 1 2 2 2 1 3 2 1 2 2 2 1 2 1 1 1 1 90 22 46 36 3 2 1 2 6 n 2 2 r c 124 80
68 18 2 3 4 1 1 1 2 2 1 1 2 4 1 1 1 1 1 1 2 2 40 36 17 12 1 0 1 2 12 n 0 0 ir c 98 40
69 26 2 4 3 2 1 1 1 1 3 2 1 5 1 1 1 1 1 2 2 1 10 20 24 24 1 0 1 2 24 n 0 0 r c 73 85
70 20 1 3 2 2 1 1 1 2 2 1 3 2 2 2 2 2 1 2 1 1 30 32 18 24 2 1 1 2 12 n 0 0 ir c 118 80
71 26 2 3 2 2 2 1 2 2 2 1 5 5 1 1 1 1 2 2 2 2 2 18 22 48 3 2 1 2 12 n 0 1 ir c 115 65
72 32 1 3 1 3 2 1 1 1 2 2 1 5 2 2 1 1 2 2 1 1 45 22 27 60 4 2 2 2 12 n 0 1 r c 135 60
73 42 2 1 0 1 2 2 1 1 3 2 7 1 1 1 1 1 1 2 2 2 14 14 41 12 1 0 1 2 12 n 0 2 r c 48 90
74 34 2 3 0 2 2 1 1 1 2 1 1 1 1 1 1 2 2 2 1 1 6 32 30 48 3 1 2 2 6 n 4 1 r c 95 80
75 45 1 4 3 3 2 1 1 1 1 1 0 0 2 2 2 2 2 2 2 2 40 28 33 144 5 4 1 2 12 n 0 1 r nc 93 80
76 30 2 4 3 2 1 1 1 1 1 1 4 5 1 2 1 1 2 1 1 1 7 12 22 96 4 2 2 2 12 n 0 1 r c 133 70
77 51 1 3 3 2 2 1 1 1 2 1 1 5 2 2 1 1 1 2 2 2 4 20 36 180 9 5 4 2 0 n 0 0 ir c 177 60
78 70 1 4 2 3 2 1 1 1 2 2 3 5 1 1 1 2 2 1 1 1 7 18 40 360 30 15 15 2 6 n 3 3 r c 148 80
79 68 2 3 3 2 1 1 2 1 1 1 1 5 1 1 1 1 1 2 2 2 60 27 30 456 30 20 10 2 12 n 2,3 0 r c 114 60
80 22 1 4 2 1 1 1 1 2 2 2 7 1 1 1 1 1 3 2 2 2 10 18 18 48 5 3 2 3 6 n 0 2 r c 123 75
81 65 2 3 1 1 2 2 2 1 2 1 1 3 1 1 1 2 1 2 1 1 60 29 22 516 2 1 1 3 204 n 0 0 ir c 94 70
82 60 1 1 1 2 1 1 1 1 2 2 1 5 2 2 1 1 3 2 2 2 90 22 35 300 25 3 22 3 12 p 0 0 r c 74 30
83 34 2 3 0 2 2 1 1 1 1 1 1 3 1 1 1 1 1 1 1 1 6 24 30 48 2 1 1 1 12 n 4 1 r c 46 75
84 24 2 2 0 2 2 2 1 1 1 2 1 3 1 1 1 1 2 2 1 1 3 42 20 48 1 1 0 1 48 n 0 0 r c 80 85
